<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.01227</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>IFN&#x003B3; Enhances CD64-Potentiated Phagocytosis of <italic>Treponema pallidum</italic> Opsonized with Human Syphilitic Serum by Human Macrophages</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Hawley</surname> <given-names>Kelly L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/142974"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cruz</surname> <given-names>Adriana R.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/278124"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Benjamin</surname> <given-names>Sarah J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/155246"/>
</contrib>
<contrib contrib-type="author">
<name><surname>La Vake</surname> <given-names>Carson J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cervantes</surname> <given-names>Jorge L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/439034"/>
</contrib>
<contrib contrib-type="author">
<name><surname>LeDoyt</surname> <given-names>Morgan</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ramirez</surname> <given-names>Lady G.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mandich</surname> <given-names>Daniza</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/439476"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fiel-Gan</surname> <given-names>Mary</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Caimano</surname> <given-names>Melissa J.</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/276778"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Radolf</surname> <given-names>Justin D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Salazar</surname> <given-names>Juan C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/23944"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, UConn Health</institution>, <addr-line>Farmington, CT</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Division of Infectious Diseases, Connecticut Children&#x02019;s Medical Center</institution>, <addr-line>Hartford, CT</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Centro Internacional de Entrenamiento e Investigaciones M&#x000E9;dicas (CIDEIM)</institution>, <addr-line>Cali</addr-line>, <country>Colombia</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Immunology, UConn Health</institution>, <addr-line>Farmington, CT</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Medicine, UConn Health</institution>, <addr-line>Farmington, CT</addr-line>, <country>United States</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Pathology, Hartford Hospital</institution>, <addr-line>Hartford, CT</addr-line>, <country>United States</country></aff>
<aff id="aff7"><sup>7</sup><institution>Department of Genetics and Developmental Biology, UConn Health</institution>, <addr-line>Farmington, CT</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Abhay Satoskar, The Ohio State University Columbus, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Monica E. Embers, Tulane University, United States; Sanjay Ram, University of Massachusetts Medical Center, United States; Carlos Robello, Institut Pasteur de Montevideo, Uruguay</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Juan C. Salazar, <email>jsalaza&#x00040;connecticutchildrens.org</email></corresp>
<fn fn-type="present-address" id="fn001"><p><sup>&#x02020;</sup>Present address: Jorge L. Cervantes, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States</p></fn>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1227</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>04</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Hawley, Cruz, Benjamin, La Vake, Cervantes, LeDoyt, Ramirez, Mandich, Fiel-Gan, Caimano, Radolf and Salazar.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Hawley, Cruz, Benjamin, La Vake, Cervantes, LeDoyt, Ramirez, Mandich, Fiel-Gan, Caimano, Radolf and Salazar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Syphilis is a multi-stage, sexually transmitted disease caused by the spirochete <italic>Treponema pallidum</italic> (<italic>Tp</italic>). Considered broadly, syphilis can be conceptualized as a dualistic process in which spirochete-driven inflammation, the cause of clinical manifestations, coexists to varying extents with bacterial persistence. Inflammation is elicited in the tissues, along with the persistence of spirochetes to keep driving a robust immune response while evading host defenses; this duality is best exemplified during the florid, disseminated stage called secondary syphilis (SS). SS lesions typically contain copious amounts of spirochetes along with a mixed cellular infiltrate consisting of CD4<sup>&#x0002B;</sup> T cells, CD8<sup>&#x0002B;</sup> T cells, NK cells, plasma cells, and macrophages. In the rabbit model, <italic>Tp</italic> are cleared by macrophages <italic>via</italic> antibody-mediated opsonophagocytosis. Previously, we demonstrated that human syphilitic serum (HSS) promotes efficient uptake of <italic>Tp</italic> by human monocytes and that opsonophagocytosis of <italic>Tp</italic> markedly enhances cytokine production. Herein, we used monocyte-derived macrophages to study <italic>Tp</italic>&#x02013;macrophage interactions <italic>ex vivo</italic>. In the absence of HSS, monocyte-derived macrophages internalized low numbers of <italic>Tp</italic> and secreted little cytokine (e.g., TNF). By contrast, these same macrophages internalized large numbers of unopsonized <italic>Borrelia burgdorferi</italic> and secreted robust levels of cytokines. Maturation of macrophages with M-CSF and IFN&#x003B3; resulted in a macrophage phenotype with increased expression of HLA-DR, CD14, inducible nitric oxide synthase, TLR2, TLR8, and the Fc&#x003B3; receptors (Fc&#x003B3;R) CD64 and CD16, even in the absence of LPS. Importantly, IFN&#x003B3;-polarized macrophages resulted in a statistically significant increase in opsonophagocytosis of <italic>Tp</italic> accompanied by enhanced production of cytokines, macrophage activation markers (CD40, CD80), TLRs (TLR2, TLR7, TLR8), chemokines (CCL19, CXCL10, CXCL11), and T<sub>H</sub>1-promoting cytokines (IL-12, IL-15). Finally, the blockade of Fc&#x003B3;Rs, primarily CD64, significantly diminished spirochetal uptake and proinflammatory cytokine secretion by IFN&#x003B3;-stimulated macrophages. Our <italic>ex vivo</italic> studies demonstrate the importance of CD64-potentiated uptake of opsonized <italic>Tp</italic> and suggest that IFN&#x003B3;-activated macrophages have an important role in the context of early syphilis. Our study results also provide an <italic>ex vivo</italic> surrogate system for use in future syphilis vaccine studies.</p>
</abstract>
<kwd-group>
<kwd><italic>Treponema pallidum</italic></kwd>
<kwd>human</kwd>
<kwd>macrophage</kwd>
<kwd>Fc&#x003B3; receptor</kwd>
<kwd>phagocytosis</kwd>
<kwd>phagosomal signaling</kwd>
<kwd>vaccine model</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="94"/>
<page-count count="18"/>
<word-count count="12319"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>Venereal syphilis is a multistage, sexually transmitted infection caused by the spirochetal bacterium, <italic>Treponema pallidum</italic> (<italic>Tp</italic>) (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Syphilis continues to be a major public health threat, affecting nearly 6 million people globally (<xref ref-type="bibr" rid="B3">3</xref>). In the United States, the rate of primary and secondary syphilis (SS) has more than tripled from 2.1 cases in 2000 to 6.3 cases per 100,000 in 2014 (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Syphilitic infection commences clinically with the appearance of an ulcerative lesion, known as a chancre, at the site of inoculation (<xref ref-type="bibr" rid="B2">2</xref>). However, even before the appearance of the chancre, treponemes begin to disseminate hematogenously, eventually giving rise to SS, a systemic inflammatory illness associated with diverse clinical manifestations, most commonly involving skin and mucous membranes (<xref ref-type="bibr" rid="B2">2</xref>). After weeks to months, the robust cellular and humoral responses elicited during SS gain control of the pathogen, driving down spirochetal burdens and ushering in the asymptomatic stage called latency (<xref ref-type="bibr" rid="B2">2</xref>). Approximately one-third of untreated patients will develop one of the recrudescent syndromes collectively known as tertiary syphilis (<xref ref-type="bibr" rid="B2">2</xref>). Considered broadly, syphilis can be conceptualized as a dualistic process in which spirochete-driven inflammation, the cause of clinical manifestations, coexists to varying extents with bacterial persistence.</p>
<p>Syphilitic lesions in all stages of disease contain a rich cellular infiltrate, composed primarily of lymphocytes, plasma cells and macrophages, accompanied by vasculopathic changes of varying severity (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>) capable of giving rise to a wide variety of histological patterns, including granulomata (<xref ref-type="bibr" rid="B8">8</xref>). Immunocytochemical analysis has revealed that the relative proportions of T cell subsets shifts from predominantly CD4<sup>&#x0002B;</sup> T cells in genital ulcers to a predominance of CD8<sup>&#x0002B;</sup> T cells in SS lesions (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Innate lymphocytes, more specifically NK cells, also have been identified in biopsies of skin rashes from SS patients (<xref ref-type="bibr" rid="B10">10</xref>). Transcriptional and immunofluorescent analyses have revealed that both primary and SS lesions contain classic T<sub>H</sub>1 cytokines and that multiple lymphocytic populations (CD4<sup>&#x0002B;</sup>, CD8<sup>&#x0002B;</sup>, and NK cells) can be sources of IFN&#x003B3;, the hallmark of a T<sub>H</sub>1 response (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>). The presence in human lesions of IFN&#x003B3; and activated macrophages (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B14">14</xref>) is consistent with a large body of literature from the experimental rabbit model suggesting that macrophages activated by IFN&#x003B3; (<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>) are critical for spirochete clearance. Seminal <italic>ex vivo</italic> studies by Lukehart et al. (<xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B22">22</xref>) have demonstrated that opsonic antibodies present in immune rabbit serum markedly enhance phagocytosis and killing of <italic>Tp</italic> by rabbit peritoneal macrophages. Like their rabbit counterparts, human monocytes and macrophages also require syphilitic serum for efficient spirochetal uptake (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B23">23</xref>). In addition to clearance, opsonophagocytosis of <italic>Tp</italic> also promotes a robust proinflammatory cytokine response which can be attributed to the release of spirochetal pattern-associated molecular patterns (PAMPs), most notably lipoproteins, from organisms degraded in phagosomes (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Despite the acknowledged central role of the macrophage in the immunobiology of syphilis, only recently have investigators begun to examine the interactions between <italic>Tp</italic> and human macrophages. We, like others, observed <italic>Tp</italic> infiltrating the epidermis by immunohistologic analysis of secondary syphilitic skin lesions (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Additionally, CD68<sup>&#x0002B;</sup> histiocytes were poised throughout the dermis, at the dermal-epidermal juncture and, in some cases, a few histiocytes were observed in the epidermis. CD138<sup>&#x0002B;</sup> plasma cells, a potential source of local opsonic antibodies, made up a portion of the cell-mediated inflammatory response (<xref ref-type="bibr" rid="B26">26</xref>). As in the recent communication by Marra et al. (<xref ref-type="bibr" rid="B23">23</xref>), herein we report that opsonic antibodies significantly enhance internalization of <italic>Tp</italic> by monocyte-derived human macrophages. However, we also note that IFN&#x003B3; markedly enhances the expression of CD64, the primary receptor for opsonic uptake of treponemes, providing for the first time, mechanistic evidence for the linkage of spirochetal clearance with adaptive cellular responses <italic>in vivo</italic>. IFN&#x003B3; plays a critical role in macrophage mediated responses by not only increasing opsonophagocytosis of <italic>Tp</italic> but also markedly broadening the inflammatory response of the macrophages following internalization of spirochetes, further emphasizing the interdependence of local innate and adaptive responses during syphilitic infection. However, even with IFN&#x003B3; activation, uptake of <italic>Tp</italic> by macrophages was inefficient as determined by the substantial proportion of spirochetes that were not internalized despite a lengthy preincubation in high concentrations of the anti-treponemal antibodies present in human syphilitic sera (HSS). These latter results are in accord with prior studies showing that <italic>Tp</italic> presents a paucity of surface antigenic targets at the host-pathogen interface and that spirochete populations display a high degree of heterogeneity with respect to surface antibody (Ab) binding. Our findings not only illustrate the dualistic nature of syphilis but also demonstrate the utility of an <italic>ex vivo</italic> model for teasing apart its many components.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Ethics Statement</title>
<p>This study was carried out in accordance with the recommendations of the Institutional Review Boards at UConn Health, Farmington CT and Centro Internacional de Entrenamiento e Investigaciones M&#x000E9;dicas (CIDEIM) in Cali, Colombia. All study participants were provided written informed consent. All animal experimentation was conducted following the <italic>Guide for the Care and Use of Laboratory Animals</italic> (8th Edition) and in accordance with protocols reviewed and approved by the UConn Health Institutional Animal Care and Use Committee under the auspices of Animal Welfare Assurance A347-01.</p>
</sec>
<sec id="S2-2">
<title>Immunohistochemical (IHC) Analysis of SS Skin Biopsies</title>
<p>Four micrometer sections, cut from a 4-mm punch biopsy that were fixed in 10% buffered formalin and embedded in paraffin, were stained with hematoxylin and eosin (H&#x00026;E) or labeled immunohistochemically with antibodies against CD4 (clone EP204, Epitomics, Cambridge, MA), CD8 (clone 4B11, Leica Biosystems Inc., Buffalo Grove, IL), CD56 (clone 56C04 Thermo-Scientific, Waltham, MA), CD68 (clone PG-M1, Dako, Carpinteria, CA) and CD138 (clone B-A38 Cell Marque, Rocklin, CA) using an automated immunohistochemistry staining platform (Bond Max, Leica-Microsystems, Buffalo Grove, IL). IHC detection of <italic>Tp</italic> was performed manually as previously described (<xref ref-type="bibr" rid="B10">10</xref>) using a rabbit polyclonal anti-<italic>Tp</italic> Ab (Biocare, Concord, CA, USA). Skin specimens from healthy volunteers of the same socioeconomic background and conditions were not available for analysis. Tissue known to contain <italic>Tp</italic> were used for the positive control of <italic>Tp</italic> IHCs. Additionally, secondary alone controls were used to assess any non-specific Ab binding for each Ab used.</p>
</sec>
<sec id="S2-3">
<title>Bacterial Strains</title>
<p><italic>Treponema pallidum</italic> (Nichols strain) was propagated by intratesticular inoculation of adult male New Zealand white rabbits and harvested in CMRL medium (Gibco) supplemented with 10% fetal bovine serum (FBS) (Atlantic Biologicals, Miami, FL, USA) at peak orchitis (<xref ref-type="bibr" rid="B12">12</xref>). Spirochetes were enumerated by dark-field microscopy on a Petroff-Hausser counting chamber (Hausser Scientific, Horsham, PA, USA). Virulent <italic>Borrelia burgdorferi</italic> (<italic>Bb</italic>) strain 297 encoding green fluorescent protein on a cp32-based shuttle vector (<xref ref-type="bibr" rid="B27">27</xref>) was propagated in BSK-H medium containing 6% rabbit serum (Sigma-Aldrich Chemical Co., St. Louis, MO, USA) and 400&#x02009;&#x003BC;g/ml of kanamycin (Sigma-Aldrich Chemical Co.). For macrophage incubation experiments, <italic>Bb</italic> temperature-shifted from 23 to 37&#x000B0;C were grown to late-logarithmic phase (&#x0007E;8&#x02009;&#x000D7;&#x02009;10<sup>7</sup> spirochetes/ml), washed twice with RPMI, and resuspended in RPMI to a final density of &#x0007E;3&#x02009;&#x000D7;&#x02009;10<sup>8</sup> spirochetes/ml.</p>
</sec>
<sec id="S2-4">
<title>Macrophage Maturation and Activation</title>
<p>Peripheral blood was obtained from healthy donors determined to be seronegative for syphilis by Rapid Plasma Reagin test and/or Lyme disease by enzyme-linked immunosorbent assay (ELISA) performed in the clinical laboratory at John Dempsey Hospital. Peripheral blood mononuclear cells (PBMCs) were isolated using Lymphoprep and SepMate-50 tubes in accordance with the recommendations of the manufacturer (STEMCELL Technologies, Vancouver, BC, Canada). To generate all macrophage phenotypes, 3&#x02009;&#x000D7;&#x02009;10<sup>7</sup> PBMCs were plated in 10&#x02009;cm polystyrene Petri dishes (BD Falcon) and incubated for 2&#x02009;h at 37&#x000B0;C with 5% CO<sub>2</sub>. Adherent cells were washed thoroughly with ice-cold PBS to remove non-monocyte populations. Macrophage nomenclature used throughout follows the recommendations of Murray et al. (<xref ref-type="bibr" rid="B28">28</xref>). M&#x003A6;(&#x02212;)s were generated by incubating the adherent monocytes in RPMI-1640 (RPMI) medium (Gibco, Thermo-Scientific) supplemented with 20% heat-inactivated (56&#x000B0;C for 30&#x02009;min) normal human serum (NHS) (CORNING, Corning, NY, USA) and 1% penicillin&#x02013;streptomycin (10,000&#x02009;U/ml) (Gibco) for 10&#x02009;days. M&#x003A6;(C)s were generated by incubating the adherent monocytes in RPMI, 20% heat-inactivated NHS, and 50&#x02009;ng/ml of M-CSF (Peprotech, Rocky Hill, NJ, USA) (<xref ref-type="bibr" rid="B29">29</xref>) for 10&#x02009;days. To generate M&#x003A6;(IFN&#x003B3;)s, M&#x003A6;(C)s were divided on day 7 and 2.5&#x02009;ng/ml of recombinant IFN&#x003B3; (Roche Diagnostics, Mannheim, Germany) (<xref ref-type="bibr" rid="B30">30</xref>) was added to one portion for an additional three days of incubation. Media and cytokines were replenished every 3&#x02009;days for a total of 10&#x02009;days. Because <italic>Tp</italic> lacks endotoxin and would not be encountered by macrophages in syphilitic lesions, LPS, which is often used in macrophage differentiation protocols, was omitted from all culture media.</p>
</sec>
<sec id="S2-5">
<title>Human Syphilitic Sera</title>
<p>All <italic>Tp</italic> opsonization studies were performed using a pool of deidentified sera collected from five HIV-negative primary or SS patients seen at Parkland Memorial Hospital in Dallas, TX, USA (approved for use by the Institutional Review Board of the UConn Health) (<xref ref-type="bibr" rid="B31">31</xref>). Strong reactivity of the pool with <italic>Tp</italic> proteins was confirmed by immunoblot (Trinity Biotech, Carlsbad, CA, USA, Figure S2 in Supplementary Material).</p>
</sec>
<sec id="S2-6">
<title><italic>Tp</italic> Opsonophagocytosis Assays</title>
<p>Freshly harvested <italic>Tp</italic>, adjusted to a final concentration of 3&#x02009;&#x000D7;&#x02009;10<sup>8</sup> treponemes/ml, were incubated with either 10% NHS or 10% pooled HSS for 2&#x02009;h at RT prior to addition to macrophages. Macrophages, differentiated as described above, were plated at 1&#x02009;&#x000D7;&#x02009;10<sup>5</sup> cells in 500&#x02009;&#x003BC;l of RPMI supplemented with 10% heat-inactivated FBS (Hyclone Laboratories, Inc., Logan, UT, USA) in an eight-well chamber microscopy slide (Millipore, Billerica, MA, USA). <italic>Tp</italic> were added at a multiplicity of infection (MOI) of 30:1 for 8&#x02009;h at 37&#x000B0;C with 5% CO<sub>2</sub>. All culture media and reagents were confirmed to be free of LPS contamination (&#x02264;10&#x02009;pg/ml) by Limulus amebocyte lysate assay quantification (Cambrex, MA, USA). Following incubation, supernatants were removed and macrophages were prepared for IFA to evaluate binding and uptake of treponemes. Cells were fixed and permeabilized with 2% paraformaldehyde and 0.01% Triton X-100 for 10&#x02009;min at RT. They then were rinsed with PBS, blocked with PBS containing 10% normal goat serum (NGS) for 1&#x02009;h at RT, and then incubated with rabbit polyclonal anti-<italic>Tp</italic> (1:100, Abcam, Cambridge, MA, USA) in PBS 1% NGS for 1&#x02009;h at RT. After four successive washes with PBS, the cells were then incubated with goat anti-rabbit immunoglobulin G (IgG)-Texas Red (1:500) in PBS 1% NGS for 1&#x02009;h at RT. After staining for <italic>Tp</italic>, actin cytoskeletons were stained with Phalloidin-AF488 (1:20) (Life Technologies, Carlsbad, CA, USA) for 20&#x02009;min at RT. The cells were then washed thoroughly with PBS six times, rinsed with deionized water to remove salt and allowed to air dry. Finally, Vectashield containing DAPI (Vector Laboratories, Inc., Burlingame, CA, USA) was added and samples were sealed with a coverslip. To assess binding and internalization of <italic>Tp</italic>, images of 100&#x02013;200 macrophages were acquired on an Olympus BX60 epifluorescence microscope equipped with a Retiga 2000R CCD camera (QImaging) or Ziess LSM 780 confocal microscope mounted on an inverted Axio Observer Z1. Similar numbers of macrophages were imaged for each experimental condition per biological replicate. Acquired images were processed with ImageJ (version 1.5.1&#x02009;g) (NIH, USA) and uptake was quantitated in a blinded fashion. The percentage of macrophages with bound spirochetes was quantified by dividing the number of cells with surface bound spirochetes by the total number of macrophages imaged for each condition. The percentage of spirochete-positive macrophages were calculated by dividing the number of cells containing &#x02265;1 internalized spirochetes by the total number of cells imaged. Phagocytic indices were calculated by dividing the number of degraded, internalized spirochetes by the total number of spirochete-positive macrophages for the same condition. To quantify the percentage of <italic>Tp</italic> remaining after the 8&#x02009;h incubation period, 10&#x02009;&#x003BC;l aliquots from <italic>Tp</italic>-stimulated-macrophage supernatants were enumerated, in triplicate, by dark-field microscopy. Percentage of <italic>Tp</italic> recovered was calculated using a &#x0201C;time zero&#x0201D; spirochetal count.</p>
</sec>
<sec id="S2-7">
<title><italic>Bb</italic> Phagocytosis Assays</title>
<p>M&#x003A6;(&#x02212;)s, after maturation as described above, were plated at 1&#x02009;&#x000D7;&#x02009;10<sup>5</sup> cells in 500&#x02009;&#x003BC;l of RPMI supplemented with 10% FBS in an eight-well chamber microscopy slide and incubated at 37&#x000B0;C with 5% CO<sub>2</sub> overnight to allow for attachment. Prior to incubation, medium was removed and replaced with fresh RPMI supplemented with 10% FBS. <italic>Bb</italic> were added at an MOI of 30:1 and incubated for 8&#x02009;h. Following incubation, cells were fixed and permeablized and cytoskeletons were stained with Phalloidin-AF594 as described above. Binding and internalization of spirochetes was performed as described above.</p>
</sec>
<sec id="S2-8">
<title>Cytokine Analysis</title>
<p>TNF, IL-6, IL-1&#x003B2;, IL-10, IL-12, and IL-8 were measured in supernatants using a Human Inflammatory Cytokine Bead Array per the manufacturer&#x02019;s (BD Biosciences, San Jose, CA, USA) protocol. Data were collected on a MACSQaunt Analyzer (Miltenyi Biotec, Germany) and analyzed with FCAP Array&#x02122; Software version 3.0 (BD Biosciences).</p>
</sec>
<sec id="S2-9">
<title>Flow Cytometry</title>
<p>M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s were harvested from 10-cm polystyrene Petri dishes by replacing growth medium with PBS containing 1% FBS and gently lifting the cells with a scraper. The macrophages were washed once with PBS in 50&#x02009;ml conical tubes by spinning at 300<italic>g</italic> for 10&#x02009;min; the cells were decanted, resuspended in PBS 1% FBS, and dispensed into FACS tubes in preparation for staining. Cells were incubated for 10&#x02009;min at 4&#x000B0;C with 10&#x02009;&#x003BC;g/ml of purified human IgG (Sigma, St. Louis, MO, USA) for Fc&#x003B3; receptor (FcR) blocking, followed by a 20&#x02009;min incubation with fluorochrome-conjugated antibodies. Antibodies obtained from Biolegend (CD32-APC, CD64-PECy7, CD163-PerCP/Cy5.5, CD206-APC, anti-rabbit IgG-BV421), eBioscience (CD14-APC, CD16-PE, TLR2-FITC, TLR4-APC), Novus Biologicals (TLR7-PE, TLR8-AF647), BD Biosciences (HLA-DR-PE), Invitrogen (CD68-FITC), and Abcam [rabbit anti-human inducible nitric oxide synthase (iNOS)] were used at dilutions recommended by the manufacturers. For intracellular staining, the cells were surface-stained as described above, permeabilized in 250&#x02009;&#x003BC;l of Cytofix/Cytoperm solution (BD Biosciences) for 20&#x02009;min at 4&#x000B0;C, washed with PermWash buffer (BD Biosciences), stained with fluorochrome-conjugated antibodies (diluted in 50&#x02009;&#x003BC;l of PermWash buffer) for 30&#x02009;min at 4&#x000B0;C, and washed twice with PermWash and resuspended in FACS buffer. A minimum of 10,000 single cells events were acquired using a BD LSR-II flow cytometer and FACSDIVA&#x02122; software (BD Biosciences). Analysis of immunostaining was performed using FlowJo V10 for Mac (FlowJo LLC, Ashland, OR, USA). Mean fluorescence intensity (MFI) values were determined after subtracting background fluorescence (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</sec>
<sec id="S2-10">
<title>Targeted Array Analysis</title>
<p>1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s were plated in 1&#x02009;ml of RPMI containing 10% FBS in a 12-well tissue culture plate (Corning) and incubated with unopsonized or opsonized <italic>Tp</italic> for 8&#x02009;h at an MOI 30:1. RNAs were extracted using a NucleoSpin RNA purification kit according to the manufacturer&#x02019;s (Macherey-Nagel Inc., Bethlehem, PA, USA) instructions and their concentrations determined using a Nanodrop spectrophotometer (Thermo-Scientific). cDNA synthesis was performed using the High Capacity cDNA Archive Kit (Applied Biosystems, Waltham, MA, USA) according to the manufacturer&#x02019;s instructions. Transcripts were amplified using TaqMan<sup>&#x000AE;</sup> Human Immune Array (384-fluidics card) and TaqMan<sup>&#x000AE;</sup> Human Phagocytosis Array (96-well plate) per manufacturer&#x02019;s instructions (Applied Biosystems). Briefly, the Immune Array was performed in a 2&#x02009;&#x003BC;1 reaction volume containing 62.5&#x02009;pg of cDNA, and 1&#x02009;&#x003BC;1 of gene expression master mix. The Phagocytosis Array was processed in a 20&#x02009;&#x003BC;l reaction volume containing 5&#x02009;ng of cDNA and 10&#x02009;ml of gene expression master mix. Commercially available primers (Applied Biosystems) were used to amply transcripts for human <italic>IRF3</italic> (Hs01547283_m1), <italic>IRF5</italic> (Hs00158114_m1), <italic>IRF7</italic> (Hs00185375_m1), and <italic>IFNB</italic> (Hs00277188_s1) as described previously (<xref ref-type="bibr" rid="B33">33</xref>). Amplification reactions were performed using a 7900HT Fast Real Time thermocycler (Applied Biosystems) using the following conditions: 95&#x000B0;C for 20&#x02009;min, and 40 cycles of 95&#x000B0;C for 1&#x02009;s and 60&#x000B0;C for 20&#x02009;s. Expression levels for all transcripts were normalized to <italic>GAPDH</italic> and the relative changes in gene expression between experimental groups were calculated using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method (<xref ref-type="bibr" rid="B34">34</xref>). To identify genes differentially expressed in the presence of IFN&#x003B3; and absence of <italic>Tp</italic>, the average fold changes for unstimulated M&#x003A6;(IFN&#x003B3;)s were calculated relative to the unstimulated M&#x003A6;(C)s. To identify genes differentially expressed in the presence of <italic>Tp</italic>, relative fold changes were calculated based on the unstimulated M&#x003A6;(IFN&#x003B3;)s condition, with a two-fold change and <italic>p</italic>-value&#x02009;&#x0003C;&#x02009;0.05 threshold (Student&#x02019;s <italic>t</italic>-test) (<xref ref-type="bibr" rid="B35">35</xref>). Heat maps and graphs of the fold changes of transcript expression were generated using R statistical software, version 3.2.2 with package &#x0201C;ggplot2,&#x0201D; function &#x0201C;heatmap.2.&#x0201D; Fold change values displayed in the heat maps represent the average fold change compared to the corresponding unstimulated M&#x003A6;(IFN&#x003B3;). No clustering analysis was performed.</p>
</sec>
<sec id="S2-11">
<title>Colocalization of CD64 and <italic>Tp</italic></title>
<p>1&#x02009;&#x000D7;&#x02009;10<sup>5</sup> M&#x003A6;(IFN&#x003B3;)s were plated in 500&#x02009;&#x003BC;l of RPMI supplemented with 10% FBS in an eight-well chamber microscopy slide and incubated for 8&#x02009;h with <italic>Tp</italic> at an MOI of 30:1. Following incubation, the cells, fixed and permeablized as above, were incubated with mouse anti-human CD64 (1:25, clone 10.1, Abcam) and rabbit polyclonal anti-<italic>Tp</italic> 1&#x02009;h at RT, and then washed four times with PBS followed by incubation for 1&#x02009;h at RT with goat anti-mouse IgG-OregonGreen488 (1:200, Invitrogen, Carlsbad, CA, USA) and goat anti-rabbit IgG-Texas Red (1:500, Life Technologies). Secondary Ab alone controls were evaluated for non-specific binding (Figure S6 in Supplementary Material). Images were acquired on a Zeiss LSM 780 confocal microscope mounted on an inverted Axio Observer Z1 and processed with ImageJ as described above. Colocalization of <italic>Tp</italic> and CD64 was visualized using the ImageJ plugin &#x0201C;Colocalization&#x0201D;; the coefficient of colocalization was determined using the plugin &#x0201C;JACoP.&#x0201D;</p>
</sec>
<sec id="S2-12">
<title>Fc&#x003B3;R Blocking Experiments</title>
<p>M&#x003A6;(IFN&#x003B3;)s were pre-incubated with 10&#x02009;&#x003BC;g/ml of mouse antihuman CD64 (clone 10.1, Abcam), mouse anti-human CD32 (clone 6C4, Affymetrix eBiosciences, San Diego, CA, USA), mouse anti-human CD16 (clone 3G8, Biolegend, San Diego, CA, USA), or 10&#x02009;&#x003BC;g/ml each of all three antibodies for 1&#x02009;h prior to adding spirochetes. Opsonophagocytosis assays were performed as described above.</p>
</sec>
<sec id="S2-13">
<title>Statistics</title>
<p>General statistical analysis was conducted using GraphPad Prism 6.0&#x02009;h (GraphPad Software, San Diego, CA, USA). Phagocytic uptake/index, <italic>Tp</italic> recovery counts, cytokine concentrations, cytometric MFI ratio, and fold increase or decrease for each gene transcript assayed were compared among the different stimuli. Either a paired or unpaired Student&#x02019;s <italic>t</italic>-test (i.e., Mann&#x02013;Whitney test or Wilcoxon test) was used for comparison across two groups. For the analysis of three or more conditions, we used a non-parametric statistical test for trend analysis (Friedman&#x02019;s test with a Dunnett&#x02019;s multiple comparisons post-test analysis). For each experiment, the standard error of the mean was calculated and a <italic>p</italic>-value&#x02009;&#x0003C;&#x02009;0.05 was considered significant.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title><italic>T. pallidum</italic>-Macrophage Interactions in SS Skin Lesions</title>
<p>To set the stage for our <italic>ex vivo</italic> studies, we assessed the distribution of macrophages, lymphocytes, and plasma cells in spatial relationship to <italic>Tp</italic> within representative skin punch biopsy specimens obtained from three HIV-negative SS patients. In line with prior studies (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B36">36</xref>&#x02013;<xref ref-type="bibr" rid="B39">39</xref>), IHC analysis of SS skin biopsies revealed a rich dermal-epidermal infiltrate (Figure <xref ref-type="fig" rid="F1">1</xref>A), which in addition to CD4<sup>&#x0002B;</sup>, CD8<sup>&#x0002B;</sup>, and CD56<sup>&#x0002B;</sup> lymphocytes (Figure S1 in Supplementary Material), had large numbers of CD68<sup>&#x0002B;</sup> macrophages (<xref ref-type="bibr" rid="B40">40</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>B). Abundant CD68<sup>&#x0002B;</sup> cells were present throughout the dermis, at the dermal&#x02013;epidermal juncture, and, in some cases, surrounding vascular structures within the dermis (Figure <xref ref-type="fig" rid="F1">1</xref>B). Treponemal numbers and locations in the inflamed skin, as well as their spatial proximity with dermal macrophages, varied among samples (Figure <xref ref-type="fig" rid="F1">1</xref>C). In SS143 skin biopsy, a small cluster of CD68<sup>&#x0002B;</sup> macrophages was visualized in close proximity to a spirochete surrounding a blood vessel wall. In SS167 sample, substantial numbers of spirochetes were seen within the interstitium of the papillary dermis (Figures <xref ref-type="fig" rid="F1">1</xref>B,C). In SS133, large groups of spirochetes also were observed traversing the dermal&#x02013;epidermal junction and within the stratum basale and stratum spinosum of the epidermis (Figure <xref ref-type="fig" rid="F1">1</xref>C), whereas very few macrophages were found within the epidermis (Figure <xref ref-type="fig" rid="F1">1</xref>B). Of particular interest, CD138<sup>&#x0002B;</sup> plasma cells were commonly observed in perivascular locations and throughout the papillary dermis (Figure <xref ref-type="fig" rid="F1">1</xref>D). In concert with previously published studies (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), our current results confirm the presence of macrophages in <italic>Tp</italic> infected tissue, and suggest that the cellular environment may be involved in shaping the phenotype of macrophages, in addition to providing a local source of opsonic antibodies needed for spirochetal recognition and clearance in <italic>Tp</italic> infected tissues.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Secondary syphilis (SS) skin lesions are enriched with dermal macrophages. Representative skin biopsies obtained from three SS patients&#x02019; skin lesions were processed for hematoxylin and eosin (H&#x00026;E) and immunohistochemical (IHC) analysis. <bold>(A)</bold> H&#x00026;E-stained sections (10&#x000D7; magnification) reveal an extensive dermal&#x02013;epidermal lymphohistiocytic immune cell infiltrate with perivascular inflammatory changes. SS167 reveals mild psoriasiform hyperplasia with basal vacuolar changes. SS133 exhibits a classic lichenoid reaction pattern with basal vacuolation. <bold>(B&#x02013;D)</bold> IHC testing of sequential tissue sections <bold>(B)</bold> varying numbers of CD68<sup>&#x0002B;</sup> macrophages were observed in various locations throughout the dermis, but very few were present in the epidermis; <bold>(C)</bold> <italic>Treponema pallidum</italic> is shown in clusters and across the dermal&#x02013;epidermal barrier (20&#x000D7; magnification). Insets depict higher magnifications of the red box areas in <bold>(B,C)</bold>. <bold>(D)</bold> CD138<sup>&#x0002B;</sup> plasma cells (red arrows) varied in frequency and location, including the perivascular space and throughout the papillary dermis. CD138 in basal epidermis has been documented but is non-contributory.</p></caption>
<graphic xlink:href="fimmu-08-01227-g001.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>Primary Human Macrophages Phagocytose <italic>Tp</italic> in the Presence of HSS but Exhibit a Blunted Cytokine Output</title>
<p>Having confirmed that the macrophage is an important cellular element of the inflammatory response to the syphilis spirochete <italic>in vivo</italic>, we next performed <italic>ex vivo</italic> experiments to directly characterize macrophage-<italic>Tp</italic> interactions. We began by maturing adherent human monocytes into macrophages using 20% heat-inactivated NHS without additional exogenous growth factors (e.g., M-CSF). We then assessed the ability of these macrophages [M&#x003A6;(&#x02212;)] to bind and phagocytose spirochetes. As a phagocytosis control, we incubated M&#x003A6;(&#x02212;)s with <italic>Bb</italic>, a spirochetal pathogen that is readily bound and internalized by primary human phagocytes (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). As shown in Figure <xref ref-type="fig" rid="F2">2</xref>A and quantified in Figure <xref ref-type="fig" rid="F2">2</xref>B, <italic>Bb</italic> binds to M&#x003A6;(&#x02212;)s and is internalized into phagosomal vacuoles (Figures <xref ref-type="fig" rid="F2">2</xref>A,C). We then assessed if macrophages were able to similarly bind and internalize <italic>Tp</italic> in the presence or absence of NHS or with HSS. For these experiments, we first confirmed that our pooled HSS reacted with spirochetal antigens by using a <italic>Tp</italic> IgG Marblot strip test (Figure S2 in Supplementary Material). The pooled HSS was determined to be highly reactive with many of <italic>Tp</italic>&#x02019;s proteins, likely including some opsonic targets. It is important to note that we previously demonstrated that the same pooled HSS recognizes the Nichols strain variant of L4, an immunodominant extracellular loop in the &#x003B2;-barrel of BamA and opsonic target (<xref ref-type="bibr" rid="B31">31</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Spirochetal uptake and cytokine secretion by primary human macrophages. Monocyte-derived macrophages [depicted as M&#x003A6;(&#x02212;)], matured with 20% normal human serum (NHS) were stimulated with <italic>Borrelia burdorferi</italic> (<italic>Bb)</italic> or <italic>Treponema pallidum</italic> (<italic>Tp)</italic> at an multiplicity of infection (MOI) 30:1 for 8&#x02009;h. <italic>Tp</italic> were incubated alone (no sera) or, where indicated, with 10% heat inactivated NHS or human syphilitic serum (HSS). <bold>(A)</bold> Macrophage actin cytoskeleton (red), nucleus (blue), and <italic>Bb</italic> or <italic>Tp</italic> (green) were labeled and imaged as described in Section &#x0201C;<xref ref-type="sec" rid="S2">Materials and Methods</xref>.&#x0201D; Representative confocal micrographs demonstrating binding (yellow arrow) and internalization (white arrow) of spirochetes are shown as 20 consecutive compressed Z-stack panels. Dot plot in <bold>(B)</bold> shows percentage of M&#x003A6;(&#x02212;)s with surface bound spirochetes in four conditions, <italic>Bb</italic> alone and <italic>Tp</italic> with no sera, NHS, or HSS. Dot plot in <bold>(C)</bold> reveals the percentage of M&#x003A6;(&#x02212;)s containing internalized <italic>Bb</italic> and <italic>Tp</italic> in the presence of HSS (blue circles) when compared to no sera and NHS (black circles). Dot plot in <bold>(D)</bold> reveals supernatant TNF concentration (pg/ml) for M&#x003A6;(&#x02212;)s stimulated with <italic>Bb</italic> (green circles) and <italic>Tp</italic> under three different conditions. Statistical significance between <italic>Bb</italic> and no Sera <italic>Tp</italic> was determined by two-tailed Mann&#x02013;Whitney test. The statistical significance between the three <italic>Tp</italic> conditions was determined by Friedman&#x02019;s test with a Dunnett&#x02019;s multiple comparison post-test analysis. N.S., not significant, &#x0002A;<italic>p</italic>-value of &#x0003C;0.05, &#x0002A;&#x0002A;<italic>p</italic>-value of &#x0003C;0.01.</p></caption>
<graphic xlink:href="fimmu-08-01227-g002.tif"/>
</fig>
<p>As shown in Figure <xref ref-type="fig" rid="F2">2</xref>, <italic>Tp</italic> binds to macrophages with or without NHS. The observed binding does not cause a concomitant increase in bacterial uptake, which suggests that <italic>Tp</italic> attaches to a non-phagocytic receptor yet to be defined on the macrophage&#x02019;s surface. On the other hand, addition of HSS caused a significant increase in spirochetal uptake (Figures <xref ref-type="fig" rid="F2">2</xref>A,C). In line with the increased uptake of opsonized <italic>Tp</italic>, fewer spirochetes were visualized bound to the macrophage surface (Figure <xref ref-type="fig" rid="F2">2</xref>B). Interestingly, while internalization of <italic>Bb</italic> resulted in copious secretion of TNF, opsonophagocytosis of <italic>Tp</italic> did not (Figure <xref ref-type="fig" rid="F2">2</xref>D). These findings confirm that HSS promotes opsonophagocytosis of <italic>Tp</italic> by human macrophages, but also raise the possibility that the milieu in which macrophages encounter spirochetes is an important determinant of macrophage activation and cytokine production following internalization of bacteria.</p>
</sec>
<sec id="S3-3">
<title>IFN&#x003B3; Induces a Classically Activated Immunophenotype in Human Macrophages</title>
<p>The observation that cytokine production in <italic>Tp</italic> stimulated M&#x003A6;(&#x02212;)s was unexpectedly low prompted us to generate a macrophage phenotype that more closely resembles macrophages present within an IFN&#x003B3; rich syphilitic immune microenvironment <italic>in vivo</italic> (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>). To do so, human monocytes were differentiated into macrophages by adding M-CSF alone [M&#x003A6;(C)] or M-CSF with IFN&#x003B3; [M&#x003A6;(IFN&#x003B3;)] and then characterized by flow cytometry, gene transcript analysis, and cytokine responsiveness. Given that <italic>Tp</italic> is completely devoid of LPS (<xref ref-type="bibr" rid="B43">43</xref>), we omitted this potent endotoxin from our maturation protocols, whereas LPS is often used in macrophage stimulation experiments (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). To more clearly define the effect of IFN&#x003B3;, we first had to measure the expression of several markers associated with either classically and/or alternatively activated macrophages (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Expression of CD68, a well characterized macrophage marker, was unaffected by IFN&#x003B3; (Figure <xref ref-type="fig" rid="F3">3</xref>A), while expression of the antigen presentation molecule HLA-DR was appreciably increased (<xref ref-type="bibr" rid="B48">48</xref>) (Figure <xref ref-type="fig" rid="F3">3</xref>A). CD14, a glycosylphosphatidylinositol-linked membrane glycoprotein that interacts with several pattern recognition receptors (PRRs), including TLR2 and complement receptor-3 (CR3) (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B49">49</xref>&#x02013;<xref ref-type="bibr" rid="B51">51</xref>), was upregulated by IFN&#x003B3; (Figure <xref ref-type="fig" rid="F3">3</xref>A). iNOS, notorious for its vital role in antimicrobial activity as part of the oxidative burst of macrophages, was also significantly increased by IFN&#x003B3; (Figure <xref ref-type="fig" rid="F3">3</xref>B). We also assessed macrophage expression of the scavenger receptor CD163 (<xref ref-type="bibr" rid="B52">52</xref>) and the C-type lectin CD206 (<xref ref-type="bibr" rid="B29">29</xref>), which are associated with alternative macrophage activation. CD163 and CD206 were for the most part unaffected by IFN&#x003B3; (Figure <xref ref-type="fig" rid="F3">3</xref>B). We then examined the expression of TLR2, 7, and 8, which we have shown to be upregulated in SS skin lesions (<xref ref-type="bibr" rid="B10">10</xref>). Expression of TLR7 was similar between the two macrophage phenotypes. On the other hand, TLR2, which is essential for spirochetal lipoprotein recognition, and TLR8, an endosomal TLR involved in single-stranded spirochetal RNA recognition (<xref ref-type="bibr" rid="B53">53</xref>), were increased in response to IFN&#x003B3; (Figure <xref ref-type="fig" rid="F3">3</xref>C).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Flow cytometric analysis of macrophage immunophenotypic profile. Monocyte-derived macrophages were generated from healthy controls by incubating monocytes with M-CSF [M&#x003A6;(C)] for 7&#x02009;days and then a portion of the macrophages were activated with IFN&#x003B3; [M&#x003A6;(IFN&#x003B3;)] for the remaining 3&#x02009;days. M&#x003A6;(C)s (black) and M&#x003A6;(IFN&#x003B3;)s (green) from the same participant were stained for <bold>(A)</bold> macrophage markers: CD68<sub>IC</sub>, HLA-DR, CD14, <bold>(B)</bold> phenotypic markers: iNOS<sub>IC</sub>, CD163, CD206, and <bold>(C)</bold> Toll-like receptors: TLR2, TLR4, TLR7<sub>IC</sub>, TLR8<sub>IC</sub>; the filled gray histograms indicate the isotype control. Histograms are representative of a minimum of four independent experiments that were used to quantify the mean fluorescence index (MFI) ratio&#x02009;&#x000B1;&#x02009;the SD as described under Section &#x0201C;<xref ref-type="sec" rid="S2">Materials and Methods</xref>.&#x0201D; Paired Student&#x02019;s <italic>t</italic>-tests (Wilcoxon test) was used to determine statistical significance between the two macrophage phenotypes, &#x0002A;<italic>p</italic>-value of &#x0003C;0.05, &#x0002A;&#x0002A;<italic>p</italic>-value of &#x0003C;0.01. IC, intracellular staining.</p></caption>
<graphic xlink:href="fimmu-08-01227-g003.tif"/>
</fig>
<p>We further examined transcriptional differences between unstimulated M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s by using a commercially available microarray panel. As shown in Table <xref ref-type="table" rid="T1">1</xref>, several genes that code for macrophage activation markers, microbial PRRs, cytokines and chemokines, were significantly upregulated by IFN&#x003B3;. Among them, the activation markers <italic>CD40</italic> and <italic>CD80</italic>, as well as <italic>CD38</italic>, a type II transmembrane glycoprotein involved in Ca<sup>2&#x0002B;</sup> signaling during Fc&#x003B3;R-mediated bacterial uptake (<xref ref-type="bibr" rid="B54">54</xref>) were transcriptionally increased. In line with the flow cytometry results shown in Figure <xref ref-type="fig" rid="F3">3</xref>, <italic>TLR2</italic> and <italic>TLR8</italic> were also upregulated in the arrays. <italic>PTGS2</italic>, the gene which codes for COX-2 and is associated with classically activated macrophages (<xref ref-type="bibr" rid="B44">44</xref>), and several inflammatory chemokines and cytokines (<italic>CXCL11, IL1B, IL1A, IL8, IL15</italic>) involved in cellular recruitment and activation were also transcriptionally upregulated. Of particular importance, all three Fc&#x003B3;Rs (CD16, CD32, and CD64) were upregulated in M&#x003A6;(IFN&#x003B3;)s. In parallel stimulation experiments, we compared proinflammatory cytokine production in response to several TLR ligands (MMP, LPS, or R848) between M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s. We observed that, independently of the TLR ligand used, IFN&#x003B3; primed macrophages produced significantly more cytokines than non-primed M&#x003A6;(C)s (Figure S3 in Supplementary Material). Our combined observations thus confirm that M-CSF cultivated macrophages in the presence of IFN&#x003B3; exhibit a classically activated macrophage phenotype.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Transcription profile of M&#x003A6;(IFN&#x003B3;)s.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Gene transcript</th>
<th valign="top" align="left">Protein name</th>
<th valign="top" align="center">Average fold change</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="3"><bold>Activation markers</bold></td>
</tr>
<tr>
<td align="left" valign="top"><italic>CD38</italic></td>
<td align="left" valign="top">CD38</td>
<td align="center" valign="top">97.7</td>
</tr>
<tr>
<td align="left" valign="top"><italic>CD40</italic></td>
<td align="left" valign="top">CD40</td>
<td align="center" valign="top">2.0</td>
</tr>
<tr>
<td align="left" valign="top"><italic>CD80</italic></td>
<td align="left" valign="top">CD80</td>
<td align="center" valign="top">3.0</td>
</tr>
<tr>
<td align="left" valign="top"><italic>HLA-DRA</italic></td>
<td align="left" valign="top">HLA-DR &#x003B1;</td>
<td align="center" valign="top">14.8</td>
</tr>
<tr>
<td align="left" valign="top"><italic>HLA-DRB1</italic></td>
<td align="left" valign="top">HLA-DR &#x003B2;1</td>
<td align="center" valign="top">8.0</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3"><bold>Fc&#x003B3; receptors</bold></td>
</tr>
<tr>
<td align="left" valign="top"><italic>FCGR1</italic></td>
<td align="left" valign="top">CD64</td>
<td align="center" valign="top">1.9</td>
</tr>
<tr>
<td align="left" valign="top"><italic>FCGR2</italic></td>
<td align="left" valign="top">CD32</td>
<td align="center" valign="top">1.4</td>
</tr>
<tr>
<td align="left" valign="top"><italic>FCGR3</italic></td>
<td align="left" valign="top">CD16</td>
<td align="center" valign="top">1.8</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3"><bold>Toll-like receptors</bold></td>
</tr>
<tr>
<td align="left" valign="top"><italic>TLR2</italic></td>
<td align="left" valign="top">TLR2</td>
<td align="center" valign="top">2.0</td>
</tr>
<tr>
<td align="left" valign="top"><italic>TLR6</italic></td>
<td align="left" valign="top">TLR6</td>
<td align="center" valign="top">2.9</td>
</tr>
<tr>
<td align="left" valign="top"><italic>TLR8</italic></td>
<td align="left" valign="top">TLR8</td>
<td align="center" valign="top">2.7</td>
</tr>
<tr>
<td align="left" valign="top"><italic>TLR9</italic></td>
<td align="left" valign="top">TLR9</td>
<td align="center" valign="top">3.1</td>
</tr>
<tr>
<td align="left" valign="top"><italic>TLR10</italic></td>
<td align="left" valign="top">TLR10</td>
<td align="center" valign="top">4.3</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3"><bold>Enzymes</bold></td>
</tr>
<tr>
<td align="left" valign="top"><italic>PTGS2</italic></td>
<td align="left" valign="top">COX-2</td>
<td align="center" valign="top">5.7</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3"><bold>Cytokines/chemokines/growth factors</bold></td>
</tr>
<tr>
<td align="left" valign="top"><italic>CSF2</italic></td>
<td align="left" valign="top">GM-CSF</td>
<td align="center" valign="top">3.5</td>
</tr>
<tr>
<td align="left" valign="top"><italic>CSF3</italic></td>
<td align="left" valign="top">G-CSF</td>
<td align="center" valign="top">9.8</td>
</tr>
<tr>
<td align="left" valign="top"><italic>CXCL11</italic></td>
<td align="left" valign="top">CXCL11</td>
<td align="center" valign="top">5.9</td>
</tr>
<tr>
<td align="left" valign="top"><italic>IL15</italic></td>
<td align="left" valign="top">IL-15</td>
<td align="center" valign="top">6.5</td>
</tr>
<tr>
<td align="left" valign="top"><italic>IL1A</italic></td>
<td align="left" valign="top">IL-1&#x003B1;</td>
<td align="center" valign="top">4.7</td>
</tr>
<tr>
<td align="left" valign="top"><italic>IL1B</italic></td>
<td align="left" valign="top">IL-1&#x003B2;</td>
<td align="center" valign="top">4.6</td>
</tr>
<tr>
<td align="left" valign="top"><italic>IL8</italic></td>
<td align="left" valign="top">IL-8</td>
<td align="center" valign="top">8.4</td>
</tr>
<tr>
<td align="left" valign="top"><italic>TNF</italic></td>
<td align="left" valign="top">TNF</td>
<td align="center" valign="top">2.1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Target array analysis of unstimulated M&#x003A6;(IFN&#x003B3;)s vs. paired unstimulated M&#x003A6;(C)s (<italic>N</italic>&#x02009;&#x0003D;&#x02009;6)</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S3-4">
<title>IFN&#x003B3; Enhances HSS-Mediated Internalization of <italic>Tp</italic>, Inflammatory Immune Signature, and Cytokine Production by Human Macrophages</title>
<p>Having generated macrophages by closely considering the microenvironment of syphilitic skin lesions, we then asked how these cells would respond to opsonized <italic>Tp ex vivo</italic>. To address this question, we stimulated M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s with <italic>Tp</italic>, in the presence or absence of opsonic antibodies, and assessed their phagocytic potential and immune responsiveness by confocal microscopy and cytokine production, respectively. We observed binding of the spirochete to both macrophage phenotypes, irrespective of the presence of HSS (Figure S4A in Supplementary Material). Spirochetes were seen attached to the macrophages by their tips (Figure <xref ref-type="fig" rid="F4">4</xref>A, bottom left inset&#x02014;yellow arrow) and in some cases across the entire length of the bacterial surface (Figure <xref ref-type="fig" rid="F4">4</xref>A, top right inset&#x02014;blue arrow). The addition of HSS led to a marked increase in phagocytosis of <italic>Tp</italic> by both macrophage phenotypes (Figures <xref ref-type="fig" rid="F4">4</xref>A,B), although the phagocytic index was significantly greater in IFN&#x003B3; stimulated cells (Figure <xref ref-type="fig" rid="F4">4</xref>C). In agreement with enhanced uptake of opsonized spirochetes, we recovered significantly fewer spirochetes when HSS was included in the stimulation experiments (Figure S4B in Supplementary Material). <italic>Tp</italic> stimulated M&#x003A6;(IFN&#x003B3;)s secreted more TNF (Figure <xref ref-type="fig" rid="F4">4</xref>D) and IL-6 (Figure <xref ref-type="fig" rid="F4">4</xref>E) than their counterparts without IFN&#x003B3;, but neither macrophage phenotype secreted IL-1&#x003B2; (Figure <xref ref-type="fig" rid="F4">4</xref>F). Overall, these findings confirm our hypothesis that elements present within the syphilitic tissue microenvironment, specifically IFN&#x003B3;, alter macrophage uptake and responsiveness to opsonized <italic>Tp</italic>.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><italic>Treponema pallidum</italic> (<italic>Tp</italic>) uptake by IFN&#x003B3; activated M&#x003A6;s. M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s were stimulated with MOI 30:1 of <italic>Tp</italic> for 8&#x02009;h. <italic>Tp</italic> were either incubated alone (no sera) or where indicated with 10% heat inactivated normal human serum (NHS) or human syphilitic serum (HSS). <bold>(A)</bold> Following stimulation, macrophage cytoskeleton (red), <italic>Tp</italic> (green), and nucleus (blue) were labeled as described in Section &#x0201C;<xref ref-type="sec" rid="S2">Materials and Methods</xref>.&#x0201D; Representative confocal micrograph of NHS-<italic>Tp</italic> (Lower left panel, and left inset) show spirochetes binding by tip attachment as well as laying entirely against the cell surface. Confocal micrographs are a composite display of 20 consecutive Z-stack planes. Internalization of <italic>Tp</italic> was observed with HSS as shown in the two right panels. Quantification of spirochetal uptake was calculated by <bold>(B)</bold> % <italic>Tp</italic><sup>&#x0002B;</sup> macrophages and <bold>(C)</bold> phagocytic index. Phagocytosis of <italic>Tp</italic> was significantly enhanced by both HSS and IFN&#x003B3;. Cytokine bead array was used to detect inflammatory cytokines in the culture supernatants following stimulation with <italic>Tp</italic>. <bold>(D)</bold> TNF and <bold>(E)</bold> IL-6 were significantly increased by M&#x003A6;(IFN&#x003B3;)s following antibody-mediated uptake of <italic>Tp</italic>. <bold>(F)</bold> No IL-1&#x003B2; was detected in any experimental condition. The statistical significance between the <italic>Tp</italic> conditions was determined by Friedman&#x02019;s test with a Dunnett&#x02019;s multiple comparison post-test analysis. N.S., not significant, &#x0002A;<italic>p</italic>-value of &#x0003C;0.05, &#x0002A;&#x0002A;<italic>p</italic>-value of &#x0003C;0.01, &#x0002A;&#x0002A;&#x0002A;<italic>p</italic>-value of &#x0003C;0.001.</p></caption>
<graphic xlink:href="fimmu-08-01227-g004.tif"/>
</fig>
<p>To further characterize the effect of opsonized <italic>Tp</italic> on the macrophage, we used targeted phagocytic and inflammatory transcriptional array analysis. For these experiments, the relative fold changes of gene transcripts between <italic>Tp</italic> stimulated and unstimulated M&#x003A6;(IFN&#x003B3;)s were measured in three experimental conditions; <italic>Tp</italic> with no sera, with NHS and with HSS (Figure <xref ref-type="fig" rid="F5">5</xref>). We first compared genes induced in <italic>Tp</italic> stimulated M&#x003A6;(IFN&#x003B3;)s with no sera or with NHS. Consistent with our findings above, where spirochetal uptake and cytokine secretion were similar between the two conditions in the absence of HSS, we observed that transcriptional profiles were also comparable, such that none of the genes met our differential expression threshold of two-fold change and <italic>p</italic>-value of &#x0003C;0.05 (Figure S5A in Supplementary Material). On the other hand, several genes were significantly upregulated in <italic>Tp</italic> stimulated M&#x003A6;(IFN&#x003B3;)s in the presence of HSS when compared to similarly stimulated M&#x003A6;(IFN&#x003B3;)s with NHS (Figure S5B in Supplementary Material). <italic>CD38, CD40</italic> and <italic>CD80</italic> were increased, whereas the activation marker <italic>CD86</italic> varied greatly between the individual participants (Figure <xref ref-type="fig" rid="F5">5</xref>). <italic>TLR7</italic> was markedly increased in 5/6 healthy volunteer macrophages, but this increase was not statistically significant. <italic>TLR2</italic> and <italic>TLR8</italic>, which have been shown to be important in spirochetal recognition (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B55">55</xref>) were significantly upregulated as a result of Fc&#x003B3;R-mediated uptake of <italic>Tp</italic>. Given the significant upregulation of <italic>TLR8</italic> (Figure <xref ref-type="fig" rid="F5">5</xref>) and the importance of type I IFNs in response to spirochetes (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B56">56</xref>), in parallel RT-PCR experiments, we also assessed the expression of <italic>IFNB</italic>, and three interferon regulatory factors (IRFs, <italic>IRF3, IRF5</italic>, and <italic>IRF7</italic>) by RT-PCR. We observed no change in expression of <italic>IRF3</italic> and <italic>IRF5</italic> (Figure S5C in Supplementary Material). <italic>IRF7</italic> was significantly upregulated, but we did not detect a substantial change in <italic>IFNB</italic> expression (Figure S5D in Supplementary Material).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Transcriptional profile of M&#x003A6;(IFN&#x003B3;) stimulated with <italic>Treponema pallidum</italic> (<italic>Tp</italic>). Transcription profiles were determined by targeted array transcriptional analysis after stimulation of M&#x003A6;(IFN&#x003B3;)s with unopsonized [no sera or normal human serum (NHS)] or opsonized [human syphilitic serum (HSS)] <italic>Tp</italic> (MOI 30:1) for 8&#x02009;h in six-well tissue culture treated plates. Relative fold changes were normalized to the unstimulated M&#x003A6;(IFN&#x003B3;)s control for each gene and then heat maps were generated based on gene categories of interest: activation markers, Fc&#x003B3; receptors (Fc&#x003B3;Rs), TLRs, and cytokines/chemokines. Heat maps depict the <italic>Z</italic>-score of NHS-<italic>Tp</italic>30 and HSS-<italic>Tp</italic>30, based on comparing all stimulation conditions, with relative fold-changes values in corresponding gene panel. Each heat map represents an <italic>N</italic>&#x02009;&#x0003D;&#x02009;1 for individual participants, from a total of six independent experiments.</p></caption>
<graphic xlink:href="fimmu-08-01227-g005.tif"/>
</fig>
<p>We observed that many cytokine and chemokines involved in cellular recruitment as well as induction of other physiological responses, including enhanced phagocytosis, were differentially regulated in <italic>Tp</italic> stimulated M&#x003A6;(IFN&#x003B3;)s in the presence of HSS. Among them, granulocyte macrophage colony-stimulating factor (GM-CSF), which is encoded by <italic>CSF2</italic> and has been described to trigger the differentiation and exiting of monocytes from the bone marrow was upregulated. There was a strong induction of chemotactic factors, including <italic>CXCL10</italic> and <italic>CXCL11</italic>, which are important for recruitment of monocytes/macrophages to the site of infection. <italic>IL12B</italic>, which is known to stimulate T cells and NK cells to secrete IFN&#x003B3;, was robustly increased in 5/6 healthy volunteer macrophages. The transcript for <italic>IL15</italic> (Figure <xref ref-type="fig" rid="F5">5</xref>), a strong NK cell activating cytokine (<xref ref-type="bibr" rid="B57">57</xref>), was also elevated. Although IL-1&#x003B2; protein was not secreted by the macrophages following <italic>Tp</italic> stimulation (Figure <xref ref-type="fig" rid="F4">4</xref>D), <italic>IL1B</italic> was transcriptionally upregulated (Figure <xref ref-type="fig" rid="F5">5</xref>). The findings together suggest that neither <italic>Tp</italic> nor its PAMPs, escape the phagosome into the cytosol to induce caspase activation and cleavage of pro-IL-1&#x003B2; into the active cytokine in accord with the mechanism detailed by Netea et al. (<xref ref-type="bibr" rid="B58">58</xref>).</p>
</sec>
<sec id="S3-5">
<title>CD64 Is Primarily Responsible for Macrophage Driven Opsonophagocytosis of <italic>Tp</italic></title>
<p>Fc&#x003B3; receptors have been observed to be upregulated in syphilitic skin lesions by transcriptional analysis (<xref ref-type="bibr" rid="B10">10</xref>) and are important for binding of IgG with various receptor&#x02013;ligand affinities (<xref ref-type="bibr" rid="B59">59</xref>). Based on our primary human macrophage data (Figures <xref ref-type="fig" rid="F2">2</xref>A and <xref ref-type="fig" rid="F4">4</xref>A) and published studies (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B23">23</xref>) demonstrating the importance of HSS in spirochetal uptake, we hypothesized that Fc&#x003B3;Rs are the major phagocytic receptors for <italic>Tp</italic>. To study this premise, we first assessed the effect of IFN&#x003B3; on CD16, CD32, and CD64 expression by flow cytometry. Expression of CD16 (Fc&#x003B3;RIII), which weakly binds IgG (<xref ref-type="bibr" rid="B59">59</xref>), was only mildly affected by IFN&#x003B3;, while expression of CD32 (Fc&#x003B3;RII), another low affinity IgG binder, was not affected (Figure <xref ref-type="fig" rid="F6">6</xref>A). Conversely, expression of CD64 (Fc&#x003B3;RI), a high affinity receptor which binds IgG, specifically IgG<sub>1</sub> and IgG<sub>3</sub> (<xref ref-type="bibr" rid="B59">59</xref>), was significantly upregulated by IFN&#x003B3; (Figures <xref ref-type="fig" rid="F6">6</xref>A,B).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>CD64 expression on human macrophages. M&#x003A6;(C)s (black) and M&#x003A6;(IFN&#x003B3;)s (green) from the same participant were assessed to determine the expression level of <bold>(A)</bold> Fc&#x003B3; receptors (Fc&#x003B3;Rs): CD16, CD32, and CD64 by flow cytometry. The filled gray histograms indicate the isotype control. Histograms are representative of a minimum of four independent experiments. Data of the mean fluorescence intensity (MFI) ratio&#x02009;&#x000B1;&#x02009;the SD were analyzed for statistical significance using the paired Student&#x02019;s <italic>t</italic>-test, &#x0002A;<italic>p</italic>-value of &#x0003C;0.05. <bold>(B)</bold> M&#x003A6;(C)s and M&#x003A6;(IFN&#x003B3;)s were incubated in eight-well chamber slides and expression of CD64 (green) was determined by IFA with mouse anti-human CD64 (clone 10.1) antibody. Representative confocal micrographs of CD64 expression levels shown as a composite of 10 consecutive Z-stack planes. CD64 MFI values (inset in bottom right) were calculated using ImageJ.</p></caption>
<graphic xlink:href="fimmu-08-01227-g006.tif"/>
</fig>
<p>Due to the significant increase in CD64 expression induced by IFN&#x003B3; (Figure <xref ref-type="fig" rid="F6">6</xref>A) and importance of syphilitic serum in spirochetal uptake (Figure <xref ref-type="fig" rid="F4">4</xref>C), we then assessed the localization of CD64 with both unopsonized and opsonized <italic>Tp</italic> by confocal microscopy. CD64 could be seen localizing with unopsonized <italic>Tp</italic> (Figure <xref ref-type="fig" rid="F7">7</xref>A, middle right) however when the spirochetes were opsonized with HSS, the intensity of the colocalization was more robust and is most likely a result of Fc&#x003B3;Rs clustering to the site of treponeme attachment (Figure <xref ref-type="fig" rid="F7">7</xref>A, lower right). To determine the role of Fc&#x003B3;Rs in spirochetal uptake, we used monoclonal antibodies against human CD16, CD32, and CD64 to block the interaction between opsonized spirochetes and each of the three Fc receptors and then compared bacterial uptake and inflammatory cytokine production between blocked and unblocked M&#x003A6;(IFN&#x003B3;)s. As shown in Figure <xref ref-type="fig" rid="F7">7</xref>B, there were no significant reductions in uptake by blocking CD16 or CD32. However, blockade of CD64 did cause a significant decrease in phagocytosis of opsonized spirochetes (Figure <xref ref-type="fig" rid="F7">7</xref>B), as well as TNF production (Figure <xref ref-type="fig" rid="F7">7</xref>C). This finding was not surprising because IgG1 and IgG3, the prominent IgG subclasses in syphilitic serum (<xref ref-type="bibr" rid="B60">60</xref>), are high affinity IgG subclasses known to bind CD64. Importantly, the use of monoclonal antibodies against CD64 alone, or in combination with CD16 and CD32, did not result in complete abrogation of phagocytosis (Figure <xref ref-type="fig" rid="F7">7</xref>B), suggesting that additional phagocytic receptors could have a role in <italic>Tp</italic> uptake. Taken together, these data show for the first time that CD64 acts as the primary phagocytic receptor for Fc&#x003B3;R-mediated uptake of opsonized <italic>Tp</italic>, and that IFN&#x003B3;-mediated enhanced expression of CD64 promotes Fc-receptor&#x02013;ligand interactions.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>CD64 is the primary phagocytic receptor. Mouse anti-human CD64 and polyclonal rabbit anti-<italic>Tp</italic> antibodies were used to identify locations of Fc&#x003B3; receptors (Fc&#x003B3;Rs) and spirochetes on the cell surface by confocal microscopy. <bold>(A)</bold> Colocalization of CD64 (red pixels) and <italic>Tp</italic> (green pixels) were determined by ImageJ plug-in &#x0201C;JACoP&#x0201D; and are represented by white pixels. Mander&#x02019;s colocalization coefficient values (M2), shown in the lower left corner of colocalization images in A, are indicative of the proportion of the green signal overlapping with the red signal. <bold>(B,C)</bold> The blockade of Fc&#x003B3;Rs on the surface of M&#x003A6;(IFN&#x003B3;)s was achieved by pre-incubating macrophages with 10&#x02009;&#x003BC;g/ml of mouse anti-human CD16 (clone 3C8), mouse anti-human CD32 (clone 6C4), mouse anti-human CD64 (clone 10.1), or 10&#x02009;&#x003BC;g/ml of each of the three antibodies for 1&#x02009;h prior to <italic>Tp</italic>&#x02013;macrophage stimulating at an multiplicity of infection (MOI) 30:1 with no sera, normal human serum (NHS), or human syphilitic serum (HSS) for an additional 8&#x02009;h in an eight-well chamber slide. <bold>(B)</bold> Phagocytic index is shown and compared between each of the five conditions studied. <bold>(C)</bold> Cytokine bead array was used to detect inflammatory cytokine production following stimulation with <italic>Tp</italic> and shown in the dot plot for each of the five conditions studied. The statistical significance between the <italic>Tp</italic> conditions was determined by Friedman&#x02019;s test with a Dunnett&#x02019;s multiple comparison post-test analysis. N.S., not significant, &#x0002A;<italic>p</italic>-value of &#x0003C;0.05, &#x0002A;&#x0002A;<italic>p</italic>-value of &#x0003C;0.01.</p></caption>
<graphic xlink:href="fimmu-08-01227-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Much of what is currently known about the role of the macrophage in syphilis pathogenesis emanates from several decades of <italic>in vivo</italic> and <italic>ex vivo</italic> studies using the rabbit model of infection (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B61">61</xref>&#x02013;<xref ref-type="bibr" rid="B63">63</xref>). Lukehart and Miller (<xref ref-type="bibr" rid="B19">19</xref>) demonstrated that chemically activated rabbit peritoneal macrophages phagocytose <italic>Tp ex vivo</italic> in the presence of syphilis immune rabbit sera. This landmark study was the first to underscore the importance of the macrophage in Ab-mediated uptake of the syphilis spirochete. Additional rabbit studies established that clearance of the spirochete <italic>in vivo</italic> temporally correlates with the influx of macrophages to infected tissues (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B64">64</xref>) and generation of a &#x0201C;lymphocyte factor&#x0201D; (<xref ref-type="bibr" rid="B65">65</xref>), now known to be IFN&#x003B3; (<xref ref-type="bibr" rid="B18">18</xref>). Although the rabbit model has proved to be an important resource in syphilis research, humans are the obligate host for <italic>Tp</italic>. Thus, it is critical to develop an <italic>ex vivo</italic> human model to aid in understanding the immunological responses of the natural host evoked by the bacterium. Studies to understand the role of the macrophage in human syphilis have relied on a combination of transcriptional and IHC analysis of early syphilitic lesions and are only now being explored with an <italic>ex vivo</italic> macrophage system. Only a handful of studies have evaluated human monocyte/macrophage-<italic>Tp</italic> interactions <italic>ex vivo</italic> (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B23">23</xref>). In one such study, our group showed that HSS promotes spirochetal uptake by isolated human monocytes, leading to destruction of the bacterium within phagosomal vacuoles and enhanced secretion of proinflammatory cytokines (i.e., TNF) (<xref ref-type="bibr" rid="B10">10</xref>). Recently Marra et al. described that 20&#x02013;47% of monocyte-derived-human macrophages internalized HSS opsonized spirochetes (<xref ref-type="bibr" rid="B23">23</xref>). However, the researchers did not assess the impact of the macrophage phenotype in phagocytosis or the inflammatory response elicited to the bacterium. The immunological environment provides critical information when developing a model system because macrophage phenotypic plasticity and polarization <italic>ex vivo</italic> are highly dependent on the cytokines and growth factors used in the differentiation protocols (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B66">66</xref>). We elected to carefully model the immunologic niche where macrophage&#x02013;<italic>Tp</italic> interactions are likely to occur under actual disease conditions for our system. We observed that the addition of IFN&#x003B3; enhanced the macrophage&#x02019;s phagocytic capacity for opsonized spirochetes, as well as the secretion of inflammatory cytokines. Unlike the rabbit model, where 63&#x02013;76% of the macrophages contained ingested opsonized spirochetes (<xref ref-type="bibr" rid="B19">19</xref>), the human system resulted in a much lower % of <italic>Tp</italic><sup>&#x0002B;</sup> cells and confirms the variability of uptake described by Marra et al. (<xref ref-type="bibr" rid="B23">23</xref>). We feel this result observed in the <italic>ex vivo</italic> macrophage system more accurately reflects the true duality of the disease; this duality can be observed in Figure <xref ref-type="fig" rid="F1">1</xref>, where treponemes appear to be migrating to locations that are difficult for the immune cells such as CD68<sup>&#x0002B;</sup> macrophages to access, while increasing the odds for bacterial transmission.</p>
<p>Our study results reinforce our underlying hypothesis that macrophage differentiation is an important factor for optimal treponemal recognition. In the presence of M-CSF and IFN&#x003B3; macrophages exhibited a &#x0201C;classically activated&#x0201D; phenotype (<xref ref-type="bibr" rid="B67">67</xref>) and responded to opsonized <italic>Tp</italic> by secreting large quantities of TNF. By comparison, while non-IFN&#x003B3; stimulated macrophages were also capable of internalizing opsonized spirochetes, their cytokine responsiveness was markedly decreased. The difference in cytokine responses between the two macrophage phenotypes has several potential explanations. First, IFN&#x003B3; induced expression of CD64 is likely to engender more efficient uptake of opsonized spirochetes, which translates into an increase in bacterial cargo available for signaling from within the phagosome. Second, upregulation of baseline TLR2 and TLR8 expression by IFN&#x003B3;, as shown herein, could promote more opportunities for ligation of released spirochetal PAMPs (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B53">53</xref>) and TLR signaling itself may lead to a more rapid maturation of the phagosome (<xref ref-type="bibr" rid="B68">68</xref>). Alternatively, as shown by Balce et al. (<xref ref-type="bibr" rid="B69">69</xref>) Fc&#x003B3;R-mediated phagocytosis in association with IFN&#x003B3; could facilitate phagosomal processing of proteins. IFN&#x003B3; stabilizes MyD88 (<xref ref-type="bibr" rid="B70">70</xref>), in addition to modulation of the Fc&#x003B3;R signaling cascade (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B71">71</xref>), helping to enhance the recognition response to <italic>Tp</italic>. Intriguingly, a similar decrease in cytokine production was not seen in non-IFN&#x003B3; primed <italic>Bb</italic>-stimulated macrophages. Several reasons likely account for the differential response between <italic>Bb</italic> and <italic>Tp</italic>. Although both spirochetes contain lipoproteins known to signal through TLR2 (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B72">72</xref>), <italic>Bb</italic> is larger in size than <italic>Tp</italic> and has a far richer repertoire of lipoproteins within its outer and inner membranes. In addition, <italic>Bb</italic>&#x02019;s nucleic acid is far more abundant and complex than <italic>Tp</italic>&#x02019;s, thus nucleic acid ligands are likely to have more opportunities to engage their cognate endosomal TLR receptors (i.e., TLR8). Ultimately, macrophages phagocytose <italic>Bb</italic> directly <italic>via</italic> the phagocytic receptor CR3 (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B73">73</xref>). The process does not require the presence of complement or opsonic antibodies, leads to efficient uptake of the bacterium and activation of phagosomal receptors despite the absence of IFN&#x003B3;.</p>
<p>Macrophage recognition of a bacterial pathogen is a very dynamic and complex process that involves a variety of receptors and is greatly influenced by the molecular composition and structure of the organism they encounter. Although <italic>Tp</italic> contains an abundance of highly antigenic hydrophilic polypeptides, these molecules are tethered by covalently bound N-terminal lipids to the bacterium&#x02019;s periplasmic inner membrane leaflet and thus not available for innate immune receptor (i.e., TLR1/2) sensing (<xref ref-type="bibr" rid="B74">74</xref>&#x02013;<xref ref-type="bibr" rid="B76">76</xref>). In addition, because <italic>Tp</italic> contains very few OMPs (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>), the bacterium provides limited binding sites for syphilitic opsonic antibodies (<xref ref-type="bibr" rid="B79">79</xref>). Nevertheless, our study demonstrates that HSS is able to opsonize <italic>Tp</italic> and lead to Fc&#x003B3;R-mediated uptake by human macrophages, where CD64 acts as the primary phagocytic receptor. The <italic>Tp</italic>-specific antibodies generated by the host, are primarily comprised of IgG1 and IgG3 subclasses (<xref ref-type="bibr" rid="B60">60</xref>), are known to bind to CD64 with high affinity (<xref ref-type="bibr" rid="B59">59</xref>). Clustering of CD64, as demonstrated occurs in the presence of opsonized spirochetes (Figure <xref ref-type="fig" rid="F7">7</xref>A), initiates important signal transduction events that result in internalization of the pathogen (<xref ref-type="bibr" rid="B80">80</xref>). Although receptor dimerization can be sufficient for receptor activation, beads coated with low densities of IgG, similar to what occurs with <italic>Tp</italic> (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B79">79</xref>), trigger inefficient receptor recruitment, thus slowing formation of the phagocytic cup (<xref ref-type="bibr" rid="B81">81</xref>). The heterogeneity of antibodies binding to spirochetal populations (<xref ref-type="bibr" rid="B79">79</xref>), in combination with the low density of OMPs (<xref ref-type="bibr" rid="B77">77</xref>) and fixed locations of the antigenic targets (<xref ref-type="bibr" rid="B78">78</xref>) may contribute directly to the slow phagocytic events of the treponemes previously described (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). They may also explain why a large proportion of spirochetes are capable of avoiding opsonophagocytosis (Figure S3B in Supplementary Material). IFN&#x003B3;-enhanced expression of CD64 most likely engenders more efficient uptake of opsonized spirochetes and inflammatory responses, which allow the human host to override the gridlock caused by the organisms unique OM structure and requirement of opsonic antibodies to eventually clear the pathogen.</p>
<p>Following opsonophagocytosis of a delicate pathogen, such as <italic>Tp</italic>, the acidic environment of the phagosomal vacuole disrupts the spirochete&#x02019;s OM (<xref ref-type="bibr" rid="B12">12</xref>). Liberation of once concealed spirochetal PAMPs makes them accessible to interact with their cognate receptors and initiate downstream inflammatory signals. Herein, we demonstrate that in addition to NF-&#x003BA;B mediated cytokine production, opsonized <italic>Tp</italic> induces transcription of type I interferons, several chemokines, and many other inflammatory mediators. Among them is IFN-&#x003B2;, a type I interferon known to be present in SS skin lesions (<xref ref-type="bibr" rid="B10">10</xref>), which we believe is triggered similarly to <italic>Bb, via</italic> a TLR8-IRF7 pathway (<xref ref-type="bibr" rid="B53">53</xref>). The chemokines CCL19, CXCL10, and CXCL11, are chemokines associated with recruitment of DCs, antigen engaged B cells, NK cells, and activated T cells to infected tissues (<xref ref-type="bibr" rid="B84">84</xref>&#x02013;<xref ref-type="bibr" rid="B86">86</xref>) were differentially transcribed following uptake of opsonized <italic>Tp</italic>, and were upregulated in SS skin lesions (<xref ref-type="bibr" rid="B10">10</xref>). IL-12 and IL-15, two cytokines secreted by macrophages and associated with activation of T cells and NK cells (<xref ref-type="bibr" rid="B57">57</xref>), were also transcriptionally modulated. Interestingly, activated NK cells and CD8<sup>&#x0002B;</sup> T cells, known for production of IFN&#x003B3; in response to <italic>Tp</italic> (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B14">14</xref>), are typically associated with degranulation in response to viral infection and tumor cells (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>) but <italic>Tp</italic> is an extracellular pathogen. The immunological functions elicited by CD8<sup>&#x0002B;</sup> T cells and NK cells in the syphilitic lesions are unclear, with the exception of sourcing IFN&#x003B3; for macrophage activation. It is also possible that macrophages are presenting antigen to T cells <italic>via</italic> a cross presentation mechanism and that other lymphocytes are involved in macrophage-independent mechanisms of clearance in the tissues. In short, it is clear that in the context of phagosomal signaling, the macrophage plays a fundamental role in generating proinflammatory signals in response to <italic>Tp</italic>, and also modulates innate and adaptive immune responses.</p>
<p>Venereal syphilis can be considered a battle between the ability of <italic>Tp</italic> to circumvent immune recognition and the proficiency of the host&#x02019;s innate and adaptive immune responses to search and destroy the spirochetal pathogen (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B89">89</xref>). Our results reinforce the importance of the human macrophage as a contributor in the innate immune response to <italic>Tp</italic>. They also offer new evidence that the balance between phagocytic uptake of the spirochete and the bacterium&#x02019;s ability to evade immune recognition by the macrophage is significantly influenced by the emergence of anti-treponemal opsonic antibodies, as well as the immune microenvironment where the macrophage resides. More specifically, our findings provide unequivocal confirmation that HSS markedly enhances uptake of spirochetes by human macrophages <italic>in vitro</italic>. Of particular noteworthiness, our study is the first to show that in human macrophages CD64 is the primary receptor during Fc&#x003B3;R-mediated phagocytosis of <italic>Tp</italic>. Results from this study also substantiate the importance of IFN&#x003B3;-mediated macrophage activation as a beneficial immune event that tips the balance of the battle with the spirochete in favor of the host. These findings allow us to build upon the model initially proposed by Lukehart (<xref ref-type="bibr" rid="B90">90</xref>) for the role of the human macrophage in the immunologic events that take place in the context of early syphilitic infection in humans. As shown in the model (Figure <xref ref-type="fig" rid="F8">8</xref>), phagocytosis by macrophages is central to the immune response against <italic>Tp</italic> and greatly influenced by Ab production to specific antigenic epitopes and production of IFN&#x003B3;. The model proposes that following a prolonged period of time, and many struggles to gain control of the spirochete, macrophage-dependent and -independent immune responses ultimately lead to clearance of <italic>Tp</italic> from infected tissues. Our study also indicates the potential challenges faced in the development of a vaccine against a unique bacterium that avoids host recognition. Comprehensive analysis of confirmed OMPs such as TprC, TprD, and Tp0326 by our group (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B91">91</xref>) in addition to other proteins identified by other researchers (<xref ref-type="bibr" rid="B92">92</xref>&#x02013;<xref ref-type="bibr" rid="B94">94</xref>), will be critical to better understand the surface-exposed antigenic loops of <italic>Tp</italic> that antibodies utilize for opsonization. Lastly, our <italic>ex vivo</italic> human macrophage model will provide researchers with the first human system to assess surrogate markers for syphilis vaccine candidates.</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>Proposed model of immune interplay in secondary syphilis (SS) lesions. <bold>(A)</bold> During early response to <italic>Tp</italic>, human macrophages (M&#x003A6;s) are able to bind unopsonized spirochetes but the cells phagocytose very limited numbers and many <italic>Tp</italic> are able to escape. The phagocytic process is inefficient and results in minimal inflammatory cytokine production. <bold>(B)</bold> Following antigen presentation by phagocytes, lymphocytes such as CD4<sup>&#x0002B;</sup> T cells, CD8<sup>&#x0002B;</sup> T cells, and NK cells produce IFN&#x003B3; locally. T cell activation can aid in B cell maturation and <italic>Tp</italic> specific Ab production. The antibodies are directed to various targets of the treponemes, including the spirochete&#x02019;s rare outer membrane proteins. M&#x003A6;s increase expression of Fc&#x003B3; receptors (Fc&#x003B3;Rs) in response to the IFN&#x003B3; rich microenvironment of the infected tissue and allow for enhanced phagocytosis of opsonized treponemes. Within the M&#x003A6;s&#x02019; phagosomal compartment, the spirochetes&#x02019; fragile outer membrane is degraded, liberating the once concealed pattern-associated molecular patterns (PAMPs) and ultimately resulting in interaction with TLRs, such as TLR2 and TLR8. The activated M&#x003A6;s produce elevated levels of inflammatory cytokines (TNF, IL-12, and IL-15) and chemokines, resulting in an important positive feedback loop that acts on both branches of the immune system. Ultimately, with aid from the adaptive immune system, the macrophage plays a central role in clearance of <italic>Tp</italic>.</p></caption>
<graphic xlink:href="fimmu-08-01227-g008.tif"/>
</fig>
</sec>
<sec id="S5">
<title>Ethics Statement</title>
<p>This study was carried out in accordance with the recommendations of the Institutional Review Boards at UConn Health, Farmington CT and Centro Internacional de Entrenamiento e Investigaciones M&#x000E9;dicas (CIDEIM) in Cali, Colombia. All study participants were provided written informed consent. All animal experimentation was conducted following the Guide for the Care and Use of Laboratory Animals (8th Edition) and in accordance with protocols reviewed and approved by the UConn Health Institutional Animal Care and Use Committee under the auspices of Animal Welfare Assurance A347-01.</p>
</sec>
<sec id="S6" sec-type="author-contributor">
<title>Author Contributions</title>
<p>All authors contributed to the conception, design, and analysis of experiments. KH, AC, CLV, ML, LR, and DM performed the experiments in the manuscript. KH, JR, and JS wrote the manuscript. All authors critically reviewed the manuscript for intellectual content.</p>
</sec>
<sec id="S7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We gratefully acknowledge all of the individuals that participated in the study. We thank the UConn Health Clinical Research Center for help with patient recruitment and appreciate Dr. Richard Cartun&#x02019;s assistance with the IHC analysis of the SS skin biopsies. Additionally, we appreciate Dr. Zhu Wang&#x02019;s support with statistical analysis of the data.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by NIAID grants AI0901656 (JS), AI26756 (JR) and AI29735 (JR and MC), CCMC Arrison and Burr Curtis Research funds (JS), the Fogarty/NIH grant RO3TW009172 (AC), the Colciencias grant 222956933229 (AC), the Robert E. Leet and Clara Guthrie Patterson Trust, Bank of America, N.A., Trustee (KH) and the research funds generously provided by Connecticut Children&#x02019;s Medical Center (JR and MC).</p>
</fn>
</fn-group>
<sec id="S8" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://journal.frontiersin.org/article/10.3389/fimmu.2017.01227/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fimmu.2017.01227/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="Presentation_1.PDF" id="SM1" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaFond</surname> <given-names>RE</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Biological basis for syphilis</article-title>. <source>Clin Microbiol Rev</source> (<year>2006</year>) <volume>19</volume>:<fpage>29</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.19.1.29-49.2006</pub-id><pub-id pub-id-type="pmid">16418521</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Tramont</surname> <given-names>EC</given-names></name> <name><surname>Salazar</surname> <given-names>JC</given-names></name></person-group>. <article-title>Syphilis (<italic>Treponema pallidum</italic>)</article-title>. <edition>8th ed</edition>. In: <person-group person-group-type="editor"><name><surname>Bennett</surname> <given-names>JE</given-names></name> <name><surname>Dolin</surname> <given-names>R</given-names></name> <name><surname>Blaser</surname> <given-names>MJ</given-names></name></person-group>, editors. <source>Mandell, Douglas and Bennett&#x02019;s Principles and Practice of Infectious Disease</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Churchill Livington Elsevier</publisher-name> (<year>2014</year>). p. <fpage>2684</fpage>&#x02013;<lpage>709</lpage>.</citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korenromp</surname> <given-names>EL</given-names></name> <name><surname>Wi</surname> <given-names>T</given-names></name> <name><surname>Resch</surname> <given-names>S</given-names></name> <name><surname>Stover</surname> <given-names>J</given-names></name> <name><surname>Broutet</surname> <given-names>N</given-names></name></person-group>. <article-title>Costing of National STI Program implementation for the global STI control strategy for the health sector, 2016-2021</article-title>. <source>PLoS One</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0170773</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0170773</pub-id><pub-id pub-id-type="pmid">28129372</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patton</surname> <given-names>ME</given-names></name> <name><surname>Su</surname> <given-names>JR</given-names></name> <name><surname>Nelson</surname> <given-names>R</given-names></name> <name><surname>Weinstock</surname> <given-names>H</given-names></name> <collab>Centers for Disease Control and Prevention (CDC)</collab></person-group>. <article-title>Primary and secondary syphilis &#x02013; United States, 2005-2013</article-title>. <source>MMWR Morb Mortal Wkly Rep</source> (<year>2014</year>) <volume>63</volume>:<fpage>402</fpage>&#x02013;<lpage>6</lpage>.</citation></ref>
<ref id="B5"><label>5</label><citation citation-type="book"><collab>Centers for Disease, C</collab>. <source>Sexually Transmitted Disease Surveillance 2014</source>. <publisher-loc>Atlanta</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services</publisher-name> (<year>2015</year>).</citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tosca</surname> <given-names>A</given-names></name> <name><surname>Lehou</surname> <given-names>J</given-names></name> <name><surname>Hatjivasiliou</surname> <given-names>M</given-names></name> <name><surname>Varelzidis</surname> <given-names>A</given-names></name> <name><surname>Stratigos</surname> <given-names>JD</given-names></name></person-group>. <article-title>Infiltrate of syphilitic lesions before and after treatment</article-title>. <source>Genitourin Med</source> (<year>1988</year>) <volume>64</volume>:<fpage>289</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">3264543</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engelkens</surname> <given-names>HJ</given-names></name> <name><surname>Ten Kate</surname> <given-names>FJ</given-names></name> <name><surname>Judanarso</surname> <given-names>J</given-names></name> <name><surname>Vuzevski</surname> <given-names>VD</given-names></name> <name><surname>Van Lier</surname> <given-names>JB</given-names></name> <name><surname>Godschalk</surname> <given-names>JC</given-names></name> <etal/></person-group> <article-title>The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws</article-title>. <source>Genitourin Med</source> (<year>1993</year>) <volume>69</volume>:<fpage>102</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">8509088</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rysgaard</surname> <given-names>C</given-names></name> <name><surname>Alexander</surname> <given-names>E</given-names></name> <name><surname>Swick</surname> <given-names>BL</given-names></name></person-group>. <article-title>Nodular secondary syphilis with associated granulomatous inflammation: case report and literature review</article-title>. <source>J Cutan Pathol</source> (<year>2014</year>) <volume>41</volume>:<fpage>370</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/cup.12293</pub-id><pub-id pub-id-type="pmid">24447075</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McBroom</surname> <given-names>RL</given-names></name> <name><surname>Styles</surname> <given-names>AR</given-names></name> <name><surname>Chiu</surname> <given-names>MJ</given-names></name> <name><surname>Clegg</surname> <given-names>C</given-names></name> <name><surname>Cockerell</surname> <given-names>CJ</given-names></name> <name><surname>Radolf</surname> <given-names>JD</given-names></name></person-group>. <article-title>Secondary syphilis in persons infected with and not infected with HIV-1: a comparative immunohistologic study</article-title>. <source>Am J Dermatopathol</source> (<year>1999</year>) <volume>21</volume>:<fpage>432</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1097/00000372-199910000-00005</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname> <given-names>AR</given-names></name> <name><surname>Ramirez</surname> <given-names>LG</given-names></name> <name><surname>Zuluaga</surname> <given-names>AV</given-names></name> <name><surname>Pillay</surname> <given-names>A</given-names></name> <name><surname>Abreu</surname> <given-names>C</given-names></name> <name><surname>Valencia</surname> <given-names>CA</given-names></name> <etal/></person-group> <article-title>Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartments</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2012</year>) <volume>6</volume>:<fpage>e1717</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0001717</pub-id><pub-id pub-id-type="pmid">22816000</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Voorhis</surname> <given-names>WC</given-names></name> <name><surname>Barrett</surname> <given-names>LK</given-names></name> <name><surname>Koelle</surname> <given-names>DM</given-names></name> <name><surname>Nasio</surname> <given-names>JM</given-names></name> <name><surname>Plummer</surname> <given-names>FA</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Primary and secondary syphilis lesions contain mRNA for Th1 cytokines</article-title>. <source>J Infect Dis</source> (<year>1996</year>) <volume>173</volume>:<fpage>491</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/173.2.491</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>MW</given-names></name> <name><surname>Cruz</surname> <given-names>AR</given-names></name> <name><surname>Lavake</surname> <given-names>CJ</given-names></name> <name><surname>Marzo</surname> <given-names>AL</given-names></name> <name><surname>Eggers</surname> <given-names>CH</given-names></name> <name><surname>Salazar</surname> <given-names>JC</given-names></name> <etal/></person-group> <article-title>Phagocytosis of <italic>Borrelia burgdorferi</italic> and <italic>Treponema pallidum</italic> potentiates innate immune activation and induces gamma interferon production</article-title>. <source>Infect Immun</source> (<year>2007</year>) <volume>75</volume>:<fpage>2046</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01666-06</pub-id><pub-id pub-id-type="pmid">17220323</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname> <given-names>JC</given-names></name> <name><surname>Cruz</surname> <given-names>AR</given-names></name> <name><surname>Pope</surname> <given-names>CD</given-names></name> <name><surname>Valderrama</surname> <given-names>L</given-names></name> <name><surname>Trujillo</surname> <given-names>R</given-names></name> <name><surname>Saravia</surname> <given-names>NG</given-names></name> <etal/></person-group> <article-title><italic>Treponema pallidum</italic> elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis</article-title>. <source>J Infect Dis</source> (<year>2007</year>) <volume>195</volume>:<fpage>879</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1086/511822</pub-id><pub-id pub-id-type="pmid">17299719</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stary</surname> <given-names>G</given-names></name> <name><surname>Klein</surname> <given-names>I</given-names></name> <name><surname>Bruggen</surname> <given-names>MC</given-names></name> <name><surname>Kohlhofer</surname> <given-names>S</given-names></name> <name><surname>Brunner</surname> <given-names>PM</given-names></name> <name><surname>Spazierer</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8&#x0002B; T cells?</article-title> <source>Am J Pathol</source> (<year>2010</year>) <volume>177</volume>:<fpage>2421</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2010.100277</pub-id><pub-id pub-id-type="pmid">20889558</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker-Zander</surname> <given-names>S</given-names></name> <name><surname>Sell</surname> <given-names>S</given-names></name></person-group>. <article-title>A histopathologic and immunologic study of the course of syphilis in the experimentally infected rabbit. Demonstration of long-lasting cellular immunity</article-title>. <source>Am J Pathol</source> (<year>1980</year>) <volume>101</volume>:<fpage>387</fpage>&#x02013;<lpage>414</lpage>.<pub-id pub-id-type="pmid">7001910</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name> <name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Lloyd</surname> <given-names>RM</given-names></name> <name><surname>Sell</surname> <given-names>S</given-names></name></person-group>. <article-title>Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and <italic>Treponema pallidum</italic> distribution in testicular lesions</article-title>. <source>J Immunol</source> (<year>1980</year>) <volume>124</volume>:<fpage>461</fpage>&#x02013;<lpage>7</lpage>.</citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godornes</surname> <given-names>C</given-names></name> <name><surname>Leader</surname> <given-names>BT</given-names></name> <name><surname>Molini</surname> <given-names>BJ</given-names></name> <name><surname>Centurion-Lara</surname> <given-names>A</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Quantitation of rabbit cytokine mRNA by real-time RT-PCR</article-title>. <source>Cytokine</source> (<year>2007</year>) <volume>38</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2007.04.002</pub-id><pub-id pub-id-type="pmid">17521914</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leader</surname> <given-names>BT</given-names></name> <name><surname>Godornes</surname> <given-names>C</given-names></name> <name><surname>Vanvoorhis</surname> <given-names>WC</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>CD4&#x0002B; lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis</article-title>. <source>Infect Immun</source> (<year>2007</year>) <volume>75</volume>:<fpage>3021</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01973-06</pub-id><pub-id pub-id-type="pmid">17403876</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name> <name><surname>Miller</surname> <given-names>JN</given-names></name></person-group>. <article-title>Demonstration of the in vitro phagocytosis of <italic>Treponema pallidum</italic> by rabbit peritoneal macrophages</article-title>. <source>J Immunol</source> (<year>1978</year>) <volume>121</volume>:<fpage>2014</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">361893</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Macrophage-mediated killing of opsonized <italic>Treponema pallidum</italic></article-title>. <source>J Infect Dis</source> (<year>1992</year>) <volume>165</volume>:<fpage>69</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/165.1.69</pub-id><pub-id pub-id-type="pmid">1727898</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name> <name><surname>Shaffer</surname> <given-names>JM</given-names></name> <name><surname>Baker-Zander</surname> <given-names>SA</given-names></name></person-group>. <article-title>A subpopulation of <italic>Treponema pallidum</italic> is resistant to phagocytosis: possible mechanism of persistence</article-title>. <source>J Infect Dis</source> (<year>1992</year>) <volume>166</volume>:<fpage>1449</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/166.6.1449</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Shaffer</surname> <given-names>JM</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Characterization of the serum requirement for macrophage-mediated killing of <italic>Treponema pallidum</italic> ssp. pallidum: relationship to the development of opsonizing antibodies</article-title>. <source>FEMS Immunol Med Microbiol</source> (<year>1993</year>) <volume>6</volume>:<fpage>273</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-695X.1993.tb00339.x</pub-id><pub-id pub-id-type="pmid">8499892</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>CM</given-names></name> <name><surname>Tantalo</surname> <given-names>LC</given-names></name> <name><surname>Sahi</surname> <given-names>SK</given-names></name> <name><surname>Dunaway</surname> <given-names>SB</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Reduced <italic>Treponema pallidum</italic>-specific opsonic antibody activity in HIV-infected patients with syphilis</article-title>. <source>J Infect Dis</source> (<year>2016</year>) <volume>213</volume>:<fpage>1348</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiv591</pub-id><pub-id pub-id-type="pmid">26655298</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buffet</surname> <given-names>M</given-names></name> <name><surname>Grange</surname> <given-names>PA</given-names></name> <name><surname>Gerhardt</surname> <given-names>P</given-names></name> <name><surname>Carlotti</surname> <given-names>A</given-names></name> <name><surname>Calvez</surname> <given-names>V</given-names></name> <name><surname>Bianchi</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Diagnosing <italic>Treponema pallidum</italic> in secondary syphilis by PCR and immunohistochemistry</article-title>. <source>J Invest Dermatol</source> (<year>2007</year>) <volume>127</volume>:<fpage>2345</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/sj.jid.5700888</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quatresooz</surname> <given-names>P</given-names></name> <name><surname>Pierard</surname> <given-names>GE</given-names></name></person-group>. <article-title>Perivascular cuff and spread of <italic>Treponema pallidum</italic></article-title>. <source>Dermatology</source> (<year>2009</year>) <volume>219</volume>:<fpage>259</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1159/000239970</pub-id><pub-id pub-id-type="pmid">19776536</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strieder</surname> <given-names>LR</given-names></name> <name><surname>Leon</surname> <given-names>JE</given-names></name> <name><surname>Carvalho</surname> <given-names>YR</given-names></name> <name><surname>Kaminagakura</surname> <given-names>E</given-names></name></person-group>. <article-title>Oral syphilis: report of three cases and characterization of the inflammatory cells</article-title>. <source>Ann Diagn Pathol</source> (<year>2015</year>) <volume>19</volume>:<fpage>76</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.anndiagpath.2015.01.003</pub-id><pub-id pub-id-type="pmid">25736987</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eggers</surname> <given-names>CH</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <name><surname>Radolf</surname> <given-names>JD</given-names></name></person-group>. <article-title>Sigma factor selectivity in <italic>Borrelia burgdorferi</italic>: RpoS recognition of the ospE/ospF/elp promoters is dependent on the sequence of the -10 region</article-title>. <source>Mol Microbiol</source> (<year>2006</year>) <volume>59</volume>:<fpage>1859</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05066.x</pub-id><pub-id pub-id-type="pmid">16553889</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>PJ</given-names></name> <name><surname>Allen</surname> <given-names>JE</given-names></name> <name><surname>Biswas</surname> <given-names>SK</given-names></name> <name><surname>Fisher</surname> <given-names>EA</given-names></name> <name><surname>Gilroy</surname> <given-names>DW</given-names></name> <name><surname>Goerdt</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><pub-id pub-id-type="pmid">25035950</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaguin</surname> <given-names>M</given-names></name> <name><surname>Houlbert</surname> <given-names>N</given-names></name> <name><surname>Fardel</surname> <given-names>O</given-names></name> <name><surname>Lecureur</surname> <given-names>V</given-names></name></person-group>. <article-title>Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin</article-title>. <source>Cell Immunol</source> (<year>2013</year>) <volume>281</volume>:<fpage>51</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellimm.2013.01.010</pub-id><pub-id pub-id-type="pmid">23454681</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname> <given-names>G</given-names></name> <name><surname>Nathan</surname> <given-names>C</given-names></name></person-group>. <article-title>In vitro differentiation of human macrophages with enhanced antimycobacterial activity</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<fpage>3889</fpage>&#x02013;<lpage>901</lpage>.<pub-id pub-id-type="doi">10.1172/JCI57235</pub-id><pub-id pub-id-type="pmid">21911939</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luthra</surname> <given-names>A</given-names></name> <name><surname>Anand</surname> <given-names>A</given-names></name> <name><surname>Hawley</surname> <given-names>KL</given-names></name> <name><surname>Ledoyt</surname> <given-names>M</given-names></name> <name><surname>La Vake</surname> <given-names>CJ</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <etal/></person-group> <article-title>A Homology Model reveals novel structural features and an immunodominant surface loop/opsonic target in the <italic>Treponema pallidum</italic> BamA Ortholog TP_0326</article-title>. <source>J Bacteriol</source> (<year>2015</year>) <volume>197</volume>:<fpage>1906</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00086-15</pub-id><pub-id pub-id-type="pmid">25825429</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Dickinson</surname> <given-names>B</given-names></name></person-group>. <source>Multicolor Flow Cytometry: Principles of Panel Design, Stain Index</source>. <publisher-loc>Stanford, CA</publisher-loc>: <publisher-name>ISAC</publisher-name> (<year>2004</year>).</citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cervantes</surname> <given-names>JL</given-names></name> <name><surname>Dunham-Ems</surname> <given-names>SM</given-names></name> <name><surname>La Vake</surname> <given-names>CJ</given-names></name> <name><surname>Petzke</surname> <given-names>MM</given-names></name> <name><surname>Sahay</surname> <given-names>B</given-names></name> <name><surname>Sellati</surname> <given-names>TJ</given-names></name> <etal/></person-group> <article-title>Phagosomal signaling by <italic>Borrelia burgdorferi</italic> in human monocytes involves toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2011</year>) <volume>108</volume>:<fpage>3683</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1013776108</pub-id><pub-id pub-id-type="pmid">21321205</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmittgen</surname> <given-names>TD</given-names></name> <name><surname>Livak</surname> <given-names>KJ</given-names></name></person-group>. <article-title>Analyzing real-time PCR data by the comparative C(T) method</article-title>. <source>Nat Protoc</source> (<year>2008</year>) <volume>3</volume>:<fpage>1101</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2008.73</pub-id><pub-id pub-id-type="pmid">18546601</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>DJ</given-names></name> <name><surname>Smyth</surname> <given-names>GK</given-names></name></person-group>. <article-title>Testing significance relative to a fold-change threshold is a TREAT</article-title>. <source>Bioinformatics</source> (<year>2009</year>) <volume>25</volume>:<fpage>765</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1093/bioinformatics/btp053</pub-id><pub-id pub-id-type="pmid">19176553</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Voorhis</surname> <given-names>WC</given-names></name> <name><surname>Barrett</surname> <given-names>LK</given-names></name> <name><surname>Nasio</surname> <given-names>JM</given-names></name> <name><surname>Plummer</surname> <given-names>FA</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Lesions of primary and secondary syphilis contain activated cytolytic T cells</article-title>. <source>Infect Immun</source> (<year>1996</year>) <volume>64</volume>:<fpage>1048</fpage>&#x02013;<lpage>50</lpage>.</citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baughn</surname> <given-names>RE</given-names></name> <name><surname>Musher</surname> <given-names>DM</given-names></name></person-group>. <article-title>Secondary syphilitic lesions</article-title>. <source>Clin Microbiol Rev</source> (<year>2005</year>) <volume>18</volume>:<fpage>205</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1128/CMR.18.1.205-216.2005</pub-id><pub-id pub-id-type="pmid">15653827</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Hazlett</surname> <given-names>KR</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Pathogenesis of syphilis</article-title>. In: <person-group person-group-type="editor"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>, editors. <source>Pathogenic Treponemas: Cellular and Molecular Biology</source>. <publisher-loc>Northfold, UK</publisher-loc>: <publisher-name>Caister Academic Press</publisher-name> (<year>2006</year>). p. <fpage>197</fpage>&#x02013;<lpage>236</lpage>.</citation></ref>
<ref id="B39"><label>39</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Immunology of syphilis</article-title>. In: <person-group person-group-type="editor"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>, editors. <source>Pathogenic Treponemes: Cellular and Molecular Biology</source>. <publisher-loc>Norfolk, UK</publisher-loc>: <publisher-name>Caister Academic Press</publisher-name> (<year>2006</year>). p. <fpage>285</fpage>&#x02013;<lpage>322</lpage>.</citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunisch</surname> <given-names>E</given-names></name> <name><surname>Fuhrmann</surname> <given-names>R</given-names></name> <name><surname>Roth</surname> <given-names>A</given-names></name> <name><surname>Winter</surname> <given-names>R</given-names></name> <name><surname>Lungershausen</surname> <given-names>W</given-names></name> <name><surname>Kinne</surname> <given-names>RW</given-names></name></person-group>. <article-title>Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry</article-title>. <source>Ann Rheum Dis</source> (<year>2004</year>) <volume>63</volume>:<fpage>774</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1136/ard.2003.013029</pub-id><pub-id pub-id-type="pmid">15194571</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname> <given-names>RR</given-names></name> <name><surname>Lusitani</surname> <given-names>D</given-names></name> <name><surname>De Boisfleury Chevance</surname> <given-names>A</given-names></name> <name><surname>Malawista</surname> <given-names>SE</given-names></name></person-group>. <article-title>Human phagocytic cells in the early innate immune response to <italic>Borrelia burgdorferi</italic></article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>185</volume>:<fpage>1773</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1086/340826</pub-id><pub-id pub-id-type="pmid">12085324</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname> <given-names>KL</given-names></name> <name><surname>Olson</surname> <given-names>CM</given-names> <suffix>Jr</suffix></name> <name><surname>Iglesias-Pedraz</surname> <given-names>JM</given-names></name> <name><surname>Navasa</surname> <given-names>N</given-names></name> <name><surname>Cervantes</surname> <given-names>JL</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <etal/></person-group> <article-title>CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of <italic>Borrelia burgdorferi</italic></article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>:<fpage>1228</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1112078109</pub-id><pub-id pub-id-type="pmid">22232682</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname> <given-names>CM</given-names></name> <name><surname>Norris</surname> <given-names>SJ</given-names></name> <name><surname>Weinstock</surname> <given-names>GM</given-names></name> <name><surname>White</surname> <given-names>O</given-names></name> <name><surname>Sutton</surname> <given-names>GG</given-names></name> <name><surname>Dodson</surname> <given-names>R</given-names></name> <etal/></person-group> <article-title>Complete genome sequence of <italic>Treponema pallidum</italic>, the syphilis spirochete</article-title>. <source>Science</source> (<year>1998</year>) <volume>281</volume>:<fpage>375</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1126/science.281.5375.375</pub-id><pub-id pub-id-type="pmid">9665876</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>FO</given-names></name> <name><surname>Gordon</surname> <given-names>S</given-names></name> <name><surname>Locati</surname> <given-names>M</given-names></name> <name><surname>Mantovani</surname> <given-names>A</given-names></name></person-group>. <article-title>Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>7303</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.10.7303</pub-id><pub-id pub-id-type="pmid">17082649</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Rosa</surname> <given-names>M</given-names></name> <name><surname>Malaguarnera</surname> <given-names>G</given-names></name> <name><surname>De Gregorio</surname> <given-names>C</given-names></name> <name><surname>D&#x02019;amico</surname> <given-names>F</given-names></name> <name><surname>Mazzarino</surname> <given-names>MC</given-names></name> <name><surname>Malaguarnera</surname> <given-names>L</given-names></name></person-group>. <article-title>Modulation of chitotriosidase during macrophage differentiation</article-title>. <source>Cell Biochem Biophys</source> (<year>2013</year>) <volume>66</volume>:<fpage>239</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1007/s12013-012-9471-x</pub-id><pub-id pub-id-type="pmid">23152091</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boonnak</surname> <given-names>K</given-names></name> <name><surname>Dambach</surname> <given-names>KM</given-names></name> <name><surname>Donofrio</surname> <given-names>GC</given-names></name> <name><surname>Tassaneetrithep</surname> <given-names>B</given-names></name> <name><surname>Marovich</surname> <given-names>MA</given-names></name></person-group>. <article-title>Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection</article-title>. <source>J Virol</source> (<year>2011</year>) <volume>85</volume>:<fpage>1671</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00220-10</pub-id><pub-id pub-id-type="pmid">21123382</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>PJ</given-names></name> <name><surname>Wynn</surname> <given-names>TA</given-names></name></person-group>. <article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<fpage>723</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1038/nri3073</pub-id><pub-id pub-id-type="pmid">21997792</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basham</surname> <given-names>TY</given-names></name> <name><surname>Merigan</surname> <given-names>TC</given-names></name></person-group>. <article-title>Recombinant interferon-gamma increases HLA-DR synthesis and expression</article-title>. <source>J Immunol</source> (<year>1983</year>) <volume>130</volume>:<fpage>1492</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">6403609</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname> <given-names>E</given-names></name> <name><surname>Sellati</surname> <given-names>TJ</given-names></name> <name><surname>Yoshimura</surname> <given-names>A</given-names></name> <name><surname>Flo</surname> <given-names>TH</given-names></name> <name><surname>Rawadi</surname> <given-names>G</given-names></name> <name><surname>Finberg</surname> <given-names>RW</given-names></name> <etal/></person-group> <article-title>Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products</article-title>. <source>J Biol Chem</source> (<year>1999</year>) <volume>274</volume>:<fpage>33419</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.274.47.33419</pub-id><pub-id pub-id-type="pmid">10559223</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname> <given-names>KL</given-names></name> <name><surname>Martin-Ruiz</surname> <given-names>I</given-names></name> <name><surname>Iglesias-Pedraz</surname> <given-names>JM</given-names></name> <name><surname>Berwin</surname> <given-names>B</given-names></name> <name><surname>Anguita</surname> <given-names>J</given-names></name></person-group>. <article-title>CD14 targets complement receptor 3 to lipid rafts during phagocytosis of <italic>Borrelia burgdorferi</italic></article-title>. <source>Int J Biol Sci</source> (<year>2013</year>) <volume>9</volume>:<fpage>803</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.7150/ijbs.7136</pub-id><pub-id pub-id-type="pmid">23983613</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barratt-Due</surname> <given-names>A</given-names></name> <name><surname>Pischke</surname> <given-names>SE</given-names></name> <name><surname>Nilsson</surname> <given-names>PH</given-names></name> <name><surname>Espevik</surname> <given-names>T</given-names></name> <name><surname>Mollnes</surname> <given-names>TE</given-names></name></person-group>. <article-title>Dual inhibition of complement and toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>) <volume>101</volume>(<issue>1</issue>):<fpage>193</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.3VMR0316-132R</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kittan</surname> <given-names>NA</given-names></name> <name><surname>Allen</surname> <given-names>RM</given-names></name> <name><surname>Dhaliwal</surname> <given-names>A</given-names></name> <name><surname>Cavassani</surname> <given-names>KA</given-names></name> <name><surname>Schaller</surname> <given-names>M</given-names></name> <name><surname>Gallagher</surname> <given-names>KA</given-names></name> <etal/></person-group> <article-title>Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e78045</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0078045</pub-id><pub-id pub-id-type="pmid">24205083</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cervantes</surname> <given-names>JL</given-names></name> <name><surname>La Vake</surname> <given-names>CJ</given-names></name> <name><surname>Weinerman</surname> <given-names>B</given-names></name> <name><surname>Luu</surname> <given-names>S</given-names></name> <name><surname>O&#x02019;connell</surname> <given-names>C</given-names></name> <name><surname>Verardi</surname> <given-names>PH</given-names></name> <etal/></person-group> <article-title>Human TLR8 is activated upon recognition of <italic>Borrelia burgdorferi</italic> RNA in the phagosome of human monocytes</article-title>. <source>J Leukoc Biol</source> (<year>2013</year>) <volume>94</volume>:<fpage>1231</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0413206</pub-id><pub-id pub-id-type="pmid">23906644</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>J</given-names></name> <name><surname>Park</surname> <given-names>KH</given-names></name> <name><surname>Kim</surname> <given-names>JJ</given-names></name> <name><surname>Jo</surname> <given-names>EK</given-names></name> <name><surname>Han</surname> <given-names>MK</given-names></name> <name><surname>Kim</surname> <given-names>UH</given-names></name></person-group>. <article-title>The role of CD38 in Fcgamma receptor (FcgammaR)-mediated phagocytosis in murine macrophages</article-title>. <source>J Biol Chem</source> (<year>2012</year>) <volume>287</volume>:<fpage>14502</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M111.329003</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname> <given-names>JC</given-names></name> <name><surname>Duhnam-Ems</surname> <given-names>S</given-names></name> <name><surname>La Vake</surname> <given-names>C</given-names></name> <name><surname>Cruz</surname> <given-names>AR</given-names></name> <name><surname>Moore</surname> <given-names>MW</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <etal/></person-group> <article-title>Activation of human monocytes by live <italic>Borrelia burgdorferi</italic> generates TLR2-dependent and -independent responses which include induction of IFN-beta</article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000444</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000444</pub-id><pub-id pub-id-type="pmid">19461888</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>AC</given-names></name> <name><surname>Schwartz</surname> <given-names>I</given-names></name> <name><surname>Petzke</surname> <given-names>MM</given-names></name></person-group>. <article-title><italic>Borrelia burgdorferi</italic> RNA induces type I and III interferons via toll-like receptor 7 and contributes to production of NF-kappaB-dependent cytokines</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>:<fpage>2405</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01617-14</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattiola</surname> <given-names>I</given-names></name> <name><surname>Pesant</surname> <given-names>M</given-names></name> <name><surname>Tentorio</surname> <given-names>PF</given-names></name> <name><surname>Molgora</surname> <given-names>M</given-names></name> <name><surname>Marcenaro</surname> <given-names>E</given-names></name> <name><surname>Lugli</surname> <given-names>E</given-names></name> <etal/></person-group> <article-title>Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<fpage>2818</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1500325</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname> <given-names>MG</given-names></name> <name><surname>Nold-Petry</surname> <given-names>CA</given-names></name> <name><surname>Nold</surname> <given-names>MF</given-names></name> <name><surname>Joosten</surname> <given-names>LA</given-names></name> <name><surname>Opitz</surname> <given-names>B</given-names></name> <name><surname>Van Der Meer</surname> <given-names>JH</given-names></name> <etal/></person-group> <article-title>Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages</article-title>. <source>Blood</source> (<year>2009</year>) <volume>113</volume>:<fpage>2324</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2008-03-146720</pub-id><pub-id pub-id-type="pmid">19104081</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname> <given-names>M</given-names></name> <name><surname>Bruhns</surname> <given-names>P</given-names></name> <name><surname>Saeys</surname> <given-names>Y</given-names></name> <name><surname>Hammad</surname> <given-names>H</given-names></name> <name><surname>Lambrecht</surname> <given-names>BN</given-names></name></person-group>. <article-title>The function of Fcgamma receptors in dendritic cells and macrophages</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<fpage>94</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="doi">10.1038/nri3582</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baughn</surname> <given-names>RE</given-names></name> <name><surname>Jorizzo</surname> <given-names>JL</given-names></name> <name><surname>Adams</surname> <given-names>CB</given-names></name> <name><surname>Musher</surname> <given-names>DM</given-names></name></person-group>. <article-title>Ig class and IgG subclass responses to <italic>Treponema pallidum</italic> in patients with syphilis</article-title>. <source>J Clin Immunol</source> (<year>1988</year>) <volume>8</volume>:<fpage>128</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1007/BF00917901</pub-id><pub-id pub-id-type="pmid">3286675</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name> <name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Sell</surname> <given-names>S</given-names></name></person-group>. <article-title>Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and <italic>Treponema pallidum</italic> antigens</article-title>. <source>J Immunol</source> (<year>1980</year>) <volume>124</volume>:<fpage>454</fpage>&#x02013;<lpage>60</lpage>.</citation></ref>
<ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alderete</surname> <given-names>JF</given-names></name> <name><surname>Baseman</surname> <given-names>JB</given-names></name></person-group>. <article-title>Analysis of serum IgG against <italic>Treponema pallidum</italic> protein antigens in experimentally infected rabbits</article-title>. <source>Br J Vener Dis</source> (<year>1981</year>) <volume>57</volume>:<fpage>302</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">7028207</pub-id></citation></ref>
<ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Sell</surname> <given-names>S</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Serum regulation of in vitro lymphocyte responses in early experimental syphilis</article-title>. <source>Infect Immun</source> (<year>1982</year>) <volume>37</volume>:<fpage>568</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">6749683</pub-id></citation></ref>
<ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sell</surname> <given-names>S</given-names></name> <name><surname>Gamboa</surname> <given-names>D</given-names></name> <name><surname>Baker-Zander</surname> <given-names>SA</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name> <name><surname>Miller</surname> <given-names>JN</given-names></name></person-group>. <article-title>Host response to <italic>Treponema pallidum</italic> in intradermally-infected rabbits: evidence for persistence of infection at local and distant sites</article-title>. <source>J Invest Dermatol</source> (<year>1980</year>) <volume>75</volume>:<fpage>470</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1111/1523-1747.ep12524230</pub-id><pub-id pub-id-type="pmid">7003026</pub-id></citation></ref>
<ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits</article-title>. <source>Infect Immun</source> (<year>1982</year>) <volume>37</volume>:<fpage>64</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">7049954</pub-id></citation></ref>
<ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>J</given-names></name> <name><surname>Schmidt</surname> <given-names>SV</given-names></name> <name><surname>Sander</surname> <given-names>J</given-names></name> <name><surname>Draffehn</surname> <given-names>A</given-names></name> <name><surname>Krebs</surname> <given-names>W</given-names></name> <name><surname>Quester</surname> <given-names>I</given-names></name> <etal/></person-group> <article-title>Transcriptome-based network analysis reveals a spectrum model of human macrophage activation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>:<fpage>274</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.006</pub-id><pub-id pub-id-type="pmid">24530056</pub-id></citation></ref>
<ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>FO</given-names></name> <name><surname>Gordon</surname> <given-names>S</given-names></name></person-group>. <article-title>The M1 and M2 paradigm of macrophage activation: time for reassessment</article-title>. <source>F1000Prime Rep</source> (<year>2014</year>) <volume>6</volume>:<fpage>13</fpage>.<pub-id pub-id-type="doi">10.12703/P6-13</pub-id><pub-id pub-id-type="pmid">24669294</pub-id></citation></ref>
<ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blander</surname> <given-names>JM</given-names></name> <name><surname>Medzhitov</surname> <given-names>R</given-names></name></person-group>. <article-title>Regulation of phagosome maturation by signals from toll-like receptors</article-title>. <source>Science</source> (<year>2004</year>) <volume>304</volume>:<fpage>1014</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1096158</pub-id><pub-id pub-id-type="pmid">15143282</pub-id></citation></ref>
<ref id="B69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balce</surname> <given-names>DR</given-names></name> <name><surname>Rybicka</surname> <given-names>JM</given-names></name> <name><surname>Greene</surname> <given-names>CJ</given-names></name> <name><surname>Ewanchuk</surname> <given-names>BW</given-names></name> <name><surname>Yates</surname> <given-names>RM</given-names></name></person-group>. <article-title>Ligation of FcgammaR alters phagosomal processing of protein via augmentation of NADPH oxidase activity</article-title>. <source>Traffic</source> (<year>2016</year>) <volume>17</volume>:<fpage>786</fpage>&#x02013;<lpage>802</lpage>.<pub-id pub-id-type="doi">10.1111/tra.12396</pub-id></citation></ref>
<ref id="B70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>D</given-names></name> <name><surname>Ding</surname> <given-names>A</given-names></name></person-group>. <article-title>MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<fpage>375</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1038/ni1308</pub-id><pub-id pub-id-type="pmid">16491077</pub-id></citation></ref>
<ref id="B71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname> <given-names>F</given-names></name> <name><surname>Ravetch</surname> <given-names>JV</given-names></name></person-group>. <article-title>Fcgamma receptors as regulators of immune responses</article-title>. <source>Nat Rev Immunol</source> (<year>2008</year>) <volume>8</volume>:<fpage>34</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1038/nri2206</pub-id><pub-id pub-id-type="pmid">18064051</pub-id></citation></ref>
<ref id="B72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sellati</surname> <given-names>TJ</given-names></name> <name><surname>Bouis</surname> <given-names>DA</given-names></name> <name><surname>Kitchens</surname> <given-names>RL</given-names></name> <name><surname>Darveau</surname> <given-names>RP</given-names></name> <name><surname>Pugin</surname> <given-names>J</given-names></name> <name><surname>Ulevitch</surname> <given-names>RJ</given-names></name> <etal/></person-group> <article-title><italic>Treponema pallidum</italic> and <italic>Borrelia burgdorferi</italic> lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>160</volume>:<fpage>5455</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">9605148</pub-id></citation></ref>
<ref id="B73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cinco</surname> <given-names>M</given-names></name> <name><surname>Murgia</surname> <given-names>R</given-names></name> <name><surname>Presani</surname> <given-names>G</given-names></name> <name><surname>Perticarari</surname> <given-names>S</given-names></name></person-group>. <article-title>Integrin CR3 mediates the binding of nonspecifically opsonized <italic>Borrelia burgdorferi</italic> to human phagocytes and mammalian cells</article-title>. <source>Infect Immun</source> (<year>1997</year>) <volume>65</volume>:<fpage>4784</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9353065</pub-id></citation></ref>
<ref id="B74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>DL</given-names></name> <name><surname>Chang</surname> <given-names>P</given-names></name> <name><surname>Mcdowall</surname> <given-names>AW</given-names></name> <name><surname>Radolf</surname> <given-names>JD</given-names></name></person-group>. <article-title>The outer membrane, not a coat of host proteins, limits antigenicity of virulent <italic>Treponema pallidum</italic></article-title>. <source>Infect Immun</source> (<year>1992</year>) <volume>60</volume>:<fpage>1076</fpage>&#x02013;<lpage>83</lpage>.</citation></ref>
<ref id="B75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desrosiers</surname> <given-names>DC</given-names></name> <name><surname>Anand</surname> <given-names>A</given-names></name> <name><surname>Luthra</surname> <given-names>A</given-names></name> <name><surname>Dunham-Ems</surname> <given-names>SM</given-names></name> <name><surname>Ledoyt</surname> <given-names>M</given-names></name> <name><surname>Cummings</surname> <given-names>MA</given-names></name> <etal/></person-group> <article-title>TP0326, a <italic>Treponema pallidum</italic> beta-barrel assembly machinery A (BamA) orthologue and rare outer membrane protein</article-title>. <source>Mol Microbiol</source> (<year>2011</year>) <volume>80</volume>:<fpage>1496</fpage>&#x02013;<lpage>515</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07662.x</pub-id></citation></ref>
<ref id="B76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname> <given-names>A</given-names></name> <name><surname>Luthra</surname> <given-names>A</given-names></name> <name><surname>Dunham-Ems</surname> <given-names>S</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <name><surname>Karanian</surname> <given-names>C</given-names></name> <name><surname>Ledoyt</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>TprC/D (Tp0117/131), a trimeric, pore-forming rare outer membrane protein of <italic>Treponema pallidum</italic>, has a bipartite domain structure</article-title>. <source>J Bacteriol</source> (<year>2012</year>) <volume>194</volume>:<fpage>2321</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1128/JB.00101-12</pub-id><pub-id pub-id-type="pmid">22389487</pub-id></citation></ref>
<ref id="B77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Norgard</surname> <given-names>MV</given-names></name> <name><surname>Schulz</surname> <given-names>WW</given-names></name></person-group>. <article-title>Outer membrane ultrastructure explains the limited antigenicity of virulent <italic>Treponema pallidum</italic></article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1989</year>) <volume>86</volume>:<fpage>2051</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.86.6.2051</pub-id><pub-id pub-id-type="pmid">2648388</pub-id></citation></ref>
<ref id="B78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bourell</surname> <given-names>KW</given-names></name> <name><surname>Schulz</surname> <given-names>W</given-names></name> <name><surname>Norgard</surname> <given-names>MV</given-names></name> <name><surname>Radolf</surname> <given-names>JD</given-names></name></person-group>. <article-title><italic>Treponema pallidum</italic> rare outer membrane proteins: analysis of mobility by freeze-fracture electron microscopy</article-title>. <source>J Bacteriol</source> (<year>1994</year>) <volume>176</volume>:<fpage>1598</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="doi">10.1128/jb.176.6.1598-1608.1994</pub-id><pub-id pub-id-type="pmid">8132453</pub-id></citation></ref>
<ref id="B79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>DL</given-names></name> <name><surname>Luthra</surname> <given-names>A</given-names></name> <name><surname>Dunham-Ems</surname> <given-names>S</given-names></name> <name><surname>Desrosiers</surname> <given-names>DC</given-names></name> <name><surname>Salazar</surname> <given-names>JC</given-names></name> <name><surname>Caimano</surname> <given-names>MJ</given-names></name> <etal/></person-group> <article-title>Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of <italic>Treponema pallidum</italic></article-title>. <source>Infect Immun</source> (<year>2010</year>) <volume>78</volume>:<fpage>5178</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00834-10</pub-id><pub-id pub-id-type="pmid">20876295</pub-id></citation></ref>
<ref id="B80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Poel</surname> <given-names>CE</given-names></name> <name><surname>Spaapen</surname> <given-names>RM</given-names></name> <name><surname>Van De Winkel</surname> <given-names>JG</given-names></name> <name><surname>Leusen</surname> <given-names>JH</given-names></name></person-group>. <article-title>Functional characteristics of the high affinity IgG receptor, FcgammaRI</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>2699</fpage>&#x02013;<lpage>704</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003526</pub-id></citation></ref>
<ref id="B81"><label>81</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Hoppe</surname> <given-names>AD</given-names></name> <name><surname>Swanson</surname> <given-names>JA</given-names></name></person-group>. <article-title>Coordination of Fc receptor signaling regulates cellular commitment to phagocytosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>19332</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1008248107</pub-id><pub-id pub-id-type="pmid">20974965</pub-id></citation></ref>
<ref id="B82"><label>82</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alder</surname> <given-names>JD</given-names></name> <name><surname>Friess</surname> <given-names>L</given-names></name> <name><surname>Tengowski</surname> <given-names>M</given-names></name> <name><surname>Schell</surname> <given-names>RF</given-names></name></person-group>. <article-title>Phagocytosis of opsonized <italic>Treponema pallidum</italic> subsp. pallidum proceeds slowly</article-title>. <source>Infect Immun</source> (<year>1990</year>) <volume>58</volume>:<fpage>1167</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">2182536</pub-id></citation></ref>
<ref id="B83"><label>83</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marangoni</surname> <given-names>A</given-names></name> <name><surname>Aldini</surname> <given-names>R</given-names></name> <name><surname>Guardigli</surname> <given-names>M</given-names></name> <name><surname>Sambri</surname> <given-names>V</given-names></name> <name><surname>Giacani</surname> <given-names>L</given-names></name> <name><surname>Montagnani</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Phagocytosis of <italic>Treponema pallidum</italic> and reactive oxygen species production by isolated rat Kupffer cells</article-title>. <source>Med Microbiol Immunol</source> (<year>2003</year>) <volume>192</volume>:<fpage>183</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1007/s00430-002-0162-x</pub-id><pub-id pub-id-type="pmid">12690445</pub-id></citation></ref>
<ref id="B84"><label>84</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dufour</surname> <given-names>JH</given-names></name> <name><surname>Dziejman</surname> <given-names>M</given-names></name> <name><surname>Liu</surname> <given-names>MT</given-names></name> <name><surname>Leung</surname> <given-names>JH</given-names></name> <name><surname>Lane</surname> <given-names>TE</given-names></name> <name><surname>Luster</surname> <given-names>AD</given-names></name></person-group>. <article-title>IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume>:<fpage>3195</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.168.7.3195</pub-id><pub-id pub-id-type="pmid">11907072</pub-id></citation></ref>
<ref id="B85"><label>85</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rupprecht</surname> <given-names>TA</given-names></name> <name><surname>Koedel</surname> <given-names>U</given-names></name> <name><surname>Muhlberger</surname> <given-names>B</given-names></name> <name><surname>Wilske</surname> <given-names>B</given-names></name> <name><surname>Fontana</surname> <given-names>A</given-names></name> <name><surname>Pfister</surname> <given-names>HW</given-names></name></person-group>. <article-title>CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis</article-title>. <source>J Neurol</source> (<year>2005</year>) <volume>252</volume>:<fpage>820</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1007/s00415-005-0752-9</pub-id><pub-id pub-id-type="pmid">15750703</pub-id></citation></ref>
<ref id="B86"><label>86</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname> <given-names>MA</given-names></name> <name><surname>Legler</surname> <given-names>DF</given-names></name></person-group>. <article-title>Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>) <volume>99</volume>:<fpage>869</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.2MR0815-380R</pub-id></citation></ref>
<ref id="B87"><label>87</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname> <given-names>M</given-names></name> <name><surname>Bleackley</surname> <given-names>RC</given-names></name></person-group>. <article-title>Cytotoxic T lymphocytes: all roads lead to death</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>:<fpage>401</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nri819</pub-id><pub-id pub-id-type="pmid">12093006</pub-id></citation></ref>
<ref id="B88"><label>88</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerwenka</surname> <given-names>A</given-names></name> <name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group>. <article-title>Natural killer cell memory in infection, inflammation and cancer</article-title>. <source>Nat Rev Immunol</source> (<year>2016</year>) <volume>16</volume>:<fpage>112</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2015.9</pub-id><pub-id pub-id-type="pmid">26806484</pub-id></citation></ref>
<ref id="B89"><label>89</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Deka</surname> <given-names>RK</given-names></name> <name><surname>Anand</surname> <given-names>A</given-names></name> <name><surname>Smajs</surname> <given-names>D</given-names></name> <name><surname>Norgard</surname> <given-names>MV</given-names></name> <name><surname>Yang</surname> <given-names>XF</given-names></name></person-group>. <article-title><italic>Treponema pallidum</italic>, the syphilis spirochete: making a living as a stealth pathogen</article-title>. <source>Nat Rev Microbiol</source> (<year>2016</year>) <volume>14</volume>:<fpage>744</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro.2016.141</pub-id><pub-id pub-id-type="pmid">27721440</pub-id></citation></ref>
<ref id="B90"><label>90</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Scientific monogamy: thirty years dancing with the same bug: 2007 Thomas Parran Award Lecture</article-title>. <source>Sex Transm Dis</source> (<year>2008</year>) <volume>35</volume>:<fpage>2</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1097/OLQ.0b013e318162c4f2</pub-id></citation></ref>
<ref id="B91"><label>91</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radolf</surname> <given-names>JD</given-names></name> <name><surname>Kumar</surname> <given-names>S</given-names></name></person-group>. <article-title>The <italic>Treponema pallidum</italic> outer membrane</article-title>. <source>Curr Top Microbiol Immunol</source> (<year>2017</year>).<pub-id pub-id-type="doi">10.1007/82_2017_44</pub-id></citation></ref>
<ref id="B92"><label>92</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaFond</surname> <given-names>RE</given-names></name> <name><surname>Molini</surname> <given-names>BJ</given-names></name> <name><surname>Van Voorhis</surname> <given-names>WC</given-names></name> <name><surname>Lukehart</surname> <given-names>SA</given-names></name></person-group>. <article-title>Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>6244</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00827-06</pub-id><pub-id pub-id-type="pmid">16923793</pub-id></citation></ref>
<ref id="B93"><label>93</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houston</surname> <given-names>S</given-names></name> <name><surname>Hof</surname> <given-names>R</given-names></name> <name><surname>Honeyman</surname> <given-names>L</given-names></name> <name><surname>Hassler</surname> <given-names>J</given-names></name> <name><surname>Cameron</surname> <given-names>CE</given-names></name></person-group>. <article-title>Activation and proteolytic activity of the <italic>Treponema pallidum</italic> metalloprotease, pallilysin</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>:<fpage>e1002822</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002822</pub-id><pub-id pub-id-type="pmid">22910436</pub-id></citation></ref>
<ref id="B94"><label>94</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lithgow</surname> <given-names>KV</given-names></name> <name><surname>Hof</surname> <given-names>R</given-names></name> <name><surname>Wetherell</surname> <given-names>C</given-names></name> <name><surname>Phillips</surname> <given-names>D</given-names></name> <name><surname>Houston</surname> <given-names>S</given-names></name> <name><surname>Cameron</surname> <given-names>CE</given-names></name></person-group>. <article-title>A defined syphilis vaccine candidate inhibits dissemination of <italic>Treponema pallidum</italic> subspecies pallidum</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>14273</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms14273</pub-id><pub-id pub-id-type="pmid">28145405</pub-id></citation></ref>
</ref-list>
</back>
</article>